Side Finds

Since the second quarter of 2026, Carter's carries a new item in its reconciliation to adjusted results: "IP litigation costs". It covers $1.2 million of pure defence costs in a single quarter, and the July 31, 2026 earnings release flags roughly $1 million more for the third quarter. Note 15 of the quarterly report names the cause: the company is a defendant in a matter alleging infringement of intellectual property.

What is remarkable is what is not there. Verbatim: "Given the inherent uncertainty of litigation, it is reasonably possible that we may incur a loss; however, the Company is unable to estimate the likelihood of a loss or the range of possible loss at this time." A loss is therefore considered reasonably possible — but the company names no order of magnitude. The defence costs alone already equal roughly 7 percent of adjusted quarterly operating income of $18.1 million; about the potential principal claim they say nothing at all. Anyone valuing a company at roughly $1.4 billion should know this open item exists.

Carter's reports its exit from China as a success story, and in one reading it is: the annual report for 2025 expects Vietnam, Bangladesh, Cambodia and India together to account for roughly 75 percent of fiscal 2026 product sourcing spend, and China for less than 3 percent. Two paragraphs on sits the other half of the truth: "In fiscal 2025, approximately 60% of the fabric that was used in the manufacture of our products was sourced from China" — roughly 60 percent of the fabric processed in 2025 still came from China, even if the sewing happens wherever duties are lower.

That leaves the cost base hanging on a supply chain exposed to two tariff regimes at once: the sewing country's and the fabric country's. The materiality is documented — in the first half of 2026 alone, incremental tariff costs hit cost of goods sold by roughly $78 million, about 6 percent of first-half net sales of $1,296.6 million and a multiple of the $46.5 million adjusted first-half operating income. On July 24, 2026, new tariffs of 10 to 12.5 percent on imports from roughly 60 countries took effect; a separate investigation into excess capacity is still running.

The quarterly report for the period ended July 4, 2026 contains a number that gets lost in the earnings cheer: of the roughly $26 million in Section 122 duties Carter's paid in the first half of 2026, about $18 million was still capitalised in inventory at the balance sheet date. The cash is long gone — but the amount only becomes a cost when the related goods are sold. That pushes the burden into the second half of 2026.

The order of magnitude matters: $18 million is almost exactly one full quarter of adjusted operating income ($18.1 million in the second quarter of 2026) and roughly 39 percent of the $46.5 million adjusted first-half figure. For comparison: a year earlier, as of January 3, 2026, roughly $50 million of tariff costs sat in inventory — so the same mechanism has already been at work. The July 31, 2026 earnings release explicitly weights the year's earnings contribution toward the second half because the tariff impact is larger in the first. The next quarterly report will show whether that math holds.

Every cost figure for Thacker Pass phase 1 hangs on one number: $2.93 billion of total capital expenditure per the technical report dated December 31, 2024. The earnings release of May 14, 2026 states plainly what is missing from it: "The total Capex estimate of $2.93 billion did not include any exposure to tariffs." The company now puts the potential tariff exposure for phase 1 alone at roughly $80 million to $120 million, mostly falling in 2026.

Tariffs are not the only item left out. The company also names the consequences of the Middle East conflict, higher fuel prices and general inflation as effects that were not in the old estimate. A new, definitive capital estimate has therefore been under way since the first quarter of 2026, with completion targeted for the second half of 2026.

For scale: the tariff range alone equals roughly 5 to 9 percent of the capital expenditure guidance the company issued for 2026 ($1.3 billion to $1.6 billion). How large the gap really is will be settled by the new estimate — and with it, whether the committed funding is enough.

The quarterly report (10-Q) for March 31, 2026 contains a sentence that is easy to miss: "The Company agreed to contribute an additional $120 million to the DOE Loan reserve accounts, to be funded within 12 months of the OWCA." In plain terms, Lithium Americas has committed to paying an additional $120 million into the reserve accounts of the Department of Energy loan, within twelve months of the loan amendment signed on October 7, 2025. The deadline therefore falls in October 2026.

Measured against freely available funds, that is not small change. As of March 31, 2026 the company held $758.5 million of unrestricted cash. The $120 million is roughly 16 percent of it — and it does not go into construction, it goes onto a collateral account.

The detail has a second side. The report presents the future economic split of the joint venture (59 percent Lithium Americas, 36 percent General Motors, 5 percent Department of Energy) expressly as the position before that $120 million is funded. In which direction and by how much the percentages move afterwards is not stated in the filing — but the parenthesis suggests the payment moves them at all. That reading is ours, not a company disclosure.

On June 26, 2026 Lithium Americas filed an automatic shelf registration (Form S-3ASR) with the U.S. securities regulator, the SEC. It registers the resale of up to 69,417,541 common shares — and the selling shareholder is neither a bank nor a fund, but the U.S. Department of Energy. The table in the prospectus puts the stake at 19.19 percent of voting power, measured against 361,820,478 shares outstanding as of June 24, 2026 and assuming both warrants are exercised in full.

The warrants come from the loan amendment of October 7, 2025. Since January 30, 2026 the department has held a warrant for 18,268,687 shares at an exercise price of one cent, plus a warrant for 8,656,509,695 non-voting units of the joint venture at $0.0001 each. Under a put, call and exchange agreement the second piece can be converted into shares of the parent — which is how the total reaches 69.4 million.

The notable part is not the existence of the warrants but the registration. A shelf prospectus is the precondition for a holder to sell freely on the exchange. The federal government has cleared its own path to the exit long before the mine has produced a single tonne of lithium.

On July 23, 2026, Western Union filed a current report (8-K, Item 5.02) announcing the departure of Chief Legal Officer Benjamin Adams effective November 2, 2026. The same filing contains — as a subordinate clause explaining the departure — a program that reaches far beyond one person: in 2026 the Compensation and Benefits Committee of the board approved a Voluntary Retirement Program open to all eligible U.S.-based employees. Anyone who, on or before December 31, 2027, is at least 50 years old, has five years of service, and whose age plus years of service total at least 60 may elect to retire. The benefits: six months of base salary, a prorated 2026 target annual incentive award, and continued vesting of outstanding equity awards.

That leaves the company with an open severance commitment running to the end of 2027 across a workforce of roughly 1,600 U.S. employees (as of December 31, 2025) — with costs landing only as people accept it. The materiality is already visible: severance costs rose to $8.9 million in the second quarter of 2026 from $3.5 million in the prior-year quarter, roughly 12 percent of quarterly net income of $76.7 million. On July 30, 2026, the chief executive simultaneously announced that cost reductions would be accelerated "more forcefully" in the second half.

The second-quarter 2026 earnings release reports 25 percent transaction growth for Branded Digital — transfers initiated on the company's own websites, apps and partner apps — against revenue growth of only 7 percent on a GAAP basis (6 percent adjusted). Do the arithmetic and revenue per transfer has fallen by roughly 14 percent.

This is not a one-quarter wobble. The quarterly series in the same release shows the pattern four times running: third quarter of 2025, up 12 percent transactions against up 7 percent revenue; fourth quarter, up 13 against up 7; first quarter of 2026, up 21 against up 9; second quarter, up 25 against up 7. Materiality is clear: Branded Digital accounted for 32 percent of revenue and 43 percent of transactions in the money-transfer segment in the second quarter of 2026, and that segment itself carries roughly 85 percent of consolidated revenue. The faster the digital share grows, the harder the price erosion presses on the group margin — which fell on a GAAP basis from 19 percent (full year 2025) to 13 percent in both quarters of 2026.

To fund the purchase of International Money Express (Intermex) for roughly $500 million in cash, Western Union entered into a separate credit commitment of $800.0 million on January 9, 2026, drawn only when needed. That commitment has an expiry date — and it has already moved: the draw period originally ran to July 8, 2026, and on June 17, 2026, the company amended the agreement to extend it to November 10, 2026. The quarterly report as of June 30, 2026, also notes an option to increase the commitment to as much as $1.0 billion.

The size matters: $800 million equals roughly 40 percent of the market value (order of magnitude two billion dollars, data as of August 1, 2026) and roughly 30 percent of existing borrowings of $2,697.2 million. At the same time the 2026 guidance hangs on this deal: the earnings release of July 30, 2026, assumes a close on September 1, 2026, while the final regulatory approval — from the New York State Department of Financial Services — has been outstanding since the announcement on August 10, 2025. If November 10, 2026, passes without a draw, the financing has to be extended or renegotiated a second time.

A footnote most readers will never open: Leifras has two committed credit facilities in place — JPY 1.0 billion with Chikuho Bank acting as agent, running from November 6, 2025 to November 5, 2026 (TIBOR plus 1.0 percent), and JPY 1.5 billion with Mizuho Bank as agent, from November 28, 2025 to November 30, 2026 (TIBOR plus 0.80 percent). Both carry financial and asset coverage covenants. Together the JPY 2.5 billion of committed capacity equals 135 percent of shareholders' equity (JPY 1,846,714,870 at December 31, 2025) and 7.5 times all financial debt (JPY 333,627,440).

Neither line appears to have been drawn as of March 31, 2026 — short-term bank borrowings sat unchanged at JPY 100,000,000. That is the reassuring half. The other half is the calendar: both facilities expire within 25 days of each other in November 2026, and a company that just spent most of its IPO proceeds on acquisitions will want them renewed. Renewal terms, and whether the covenants change, are the thing to read.

Everybody looks at the sports schools; the money is moving somewhere else. Leifras' social business — running school club activities for municipalities, after-school daycare and senior fitness — lifted its segment profit from JPY 16,067,513 (2023) through JPY 102,736,566 (2024) to JPY 469,103,435 (2025). That is almost a 29-fold increase in two years, and the segment margin went with it: 0.7 percent to 14.8 percent. The gain of roughly JPY 453 million over those two years is larger than the company's entire 2025 net income of JPY 438,459,617.

The tailwind is written into government budgets. The annual report cites the Japan Sports Agency as having allocated JPY 8.2 billion in the 2025 supplementary budget and JPY 5.7 billion in the 2026 budget proposal for the "Reform Implementation Period" running from 2026 to 2031, during which school club activities move to private providers. The counter-check belongs in the same breath: revenue per capita in the social business fell 9.2 percent in 2025 — this segment is growing by adding schools, not by earning more per school.

Between May and July 2026, Leifras closed three takeovers, all of them paid in cash: Well Resources Co., Ltd. (four child-development and after-school daycare facilities in Miyagi Prefecture) closed May 1, 2026 at a price of JPY 132 million including consumption tax; Tokai Sports Co., Ltd. (100 percent) closed June 1, 2026 — with the purchase price never disclosed in any filing; and SWIFT JAPAN Co., Ltd. (childcare, Aichi Prefecture) closed July 1, 2026 for JPY 454,580,040 ($2,857,556). The two disclosed prices alone add up to at least JPY 586.6 million — that is 89 percent of the entire net proceeds of the October 2025 IPO (JPY 658,666,480 per note 20 of the annual report) and 23 percent of all cash the company held at December 31, 2025 (JPY 2,524,082,266).

The detail worth flagging: on June 18, 2026 — two weeks after the second deal closed and five days before the third was signed — Leifras affirmed its full-year 2026 guidance, which states in plain words that it "is based on the assumption that no business acquisitions, restructuring activities, or legal settlements will take place during the period." Both statements are in filings made within the same month. Whichever way the arithmetic resolves, the next interim report is where it becomes visible.

In fiscal year 2025, Redwire's gross margin was just 5 percent (prior year 15 percent) — driven mainly by −$54.5 million of net EAC adjustments (cost rebookings on fixed-price contracts), after already −$17.7 million a year earlier, more than a tripling. On top came $13.6 million of non-cash purchase-accounting effects from the Edge acquisition. Gross margin recovered to 27 percent in the first quarter of 2026 — but the quarterly report does not break out EAC adjustments for the single quarter, so it cannot be verified whether the fixed-price risk has actually shrunk or simply stayed quiet for one period.

For readers who want to track this themselves: the next annual report will show the full-year net EAC adjustments for 2026 — the comparison figure is −$54.5 million (2025).

The Edge Autonomy acquisition (closed June 13, 2025) generated, per the purchase price allocation, $721.3 million of goodwill — alongside $264.8 million of developed technology, $15.4 million of customer relationships and $17.9 million of trade name. Auditor KPMG singles out this exact purchase price allocation in the annual report as a "Critical Audit Matter" — a designation reserved for balance-sheet items with unusually high judgment involved. Already in the fourth quarter of 2025, just two quarters after closing, Redwire had to write down $34.7 million ($20.9 million of it against goodwill).

For scale: $721.3 million equals roughly 68 percent of the $1,060.0 million of equity reported as of December 31, 2025. The next impairment test is due with the next annual report.

Redwire's share count rose from 66.5 million (10-Q cover page, August 4, 2024) to 198,918,728 (10-Q cover page, May 1, 2026) — up 199 percent. Alongside the Edge acquisition, the main driver is a self-escalating ATM program: the $250 million program launched in November 2025 was, per the quarterly report, effectively down to a "nominal" amount within roughly five months (average price in the first quarter of 2026: just $9.38 per share); a $350 million program followed on May 6, 2026, and on June 9, 2026 — only five weeks later — came a $500 million program with ten participating banks.

What matters for investors is less the individual tranche than the pattern: each of the three escalation steps came faster than the one before it. The next quarterly report (10-Q for Q2 2026, announced for August 5, 2026) will show the next reliable cover-page snapshot of the share count — the comparison figure is 198,918,728 shares.

Who actually sold Edge Autonomy? The annual report for 2025 names the seller as Ultimate Holdings, LP, an entity tied to the private-equity firm AE Industrial Partners (AEI). AEI financed part of the purchase price itself: a "Seller Note" of $100 million at 15 percent interest with a 1.2x minimum-return clause, which Redwire repaid in full in June 2025. That same AEI group also holds 46,505.13 Series A preferred shares of Redwire — carrying a 13 percent cash (or 15 percent payment-in-kind) dividend, a $3.05 conversion price (roughly 16.1 million common shares if converted), and a liquidation preference of $118.4 million as of December 31, 2025.

One detail is especially worth flagging: starting on the seventh anniversary of issuance, October 28, 2029, AEI can, per the quarterly report, force a sale process for the entire company — a so-called investment-banker clause. The seller of the largest acquisition in Redwire's history is therefore simultaneously the holder of a preferred stake with a built-in lever toward a future company sale — fully disclosed and entirely legal, but a setup investors should keep on their radar.

Tilray Brands' beverage business grew to $254.0 million in fiscal 2026, up from $240.6 million. That sounds like growth. The annual report (10-K) filed on July 28, 2026 breaks it down differently: those $254.0 million include $51.1 million of incremental revenue from the BrewDog acquisition, which only closed in the fourth fiscal quarter. Excluding that deal, beverage revenue was roughly $202.9 million — a good 15 percent below the prior year.

The company names the reasons itself: industry-wide weakness in craft beer, spirits and brewpubs, deliberate margin actions that reduced revenue by about $16.6 million, and a change to the Farm Bill that will restrict future sales of its HD-D9 beverages and cost roughly $2.1 million during the year.

BrewDog itself did not come out of an auction but out of an insolvency process: on March 2, 2026 Tilray acquired parts of BrewDog plc through a pre-packaged administration under the U.K. Insolvency Act 1986, for a cash purchase price of £33.0 million ($44.2 million).

On July 31, 2026 — three days after the annual report — Tilray Brands filed a Form S-8 registration for 11,355,231 additional shares issuable under its Amended and Restated 2018 Equity Incentive Plan. That is roughly 8.3 percent of all shares outstanding as of July 24, 2026.

The reason is spelled out in the document itself: "Pursuant to such provision, on January 1 of each year through 2027, the number of shares authorized for issuance under the Plan is automatically increased by a number equal to four percent of the outstanding shares of Common Stock as of the end of the Registrant's immediately preceding fiscal year, or any lesser number of shares of Common Stock determined by the board of directors of the Registrant."

The mechanism needs no fresh shareholder vote. The 11,355,231 shares registered now are the sum of three annual increases: 2,970,901 shares on January 1, 2024, 3,736,909 on January 1, 2025 and 4,647,421 on January 1, 2026 — each larger than the last, because four percent of a bigger base is a bigger number.

On April 15, 2026 Tilray Brands entered into a new share issuance program of up to $180 million — an at-the-market or ATM program, under which a company sells new shares in small slices directly on the exchange. By the end of the fiscal year on May 31, 2026 it had issued 12,848,281 shares under that program for gross proceeds of $87.0 million, at an average price of $6.77.

The notable part is not the amount but the timing, which the annual report (10-K) filed on July 28, 2026 discloses itself: "A substantial portion of these shares were issued on April 22 and April 23, 2026, during a period of increased trading activity and share price appreciation following developments related to the potential U.S. cannabis rescheduling process." Anyone who bought that rally over those two days was, to a substantial extent, buying freshly printed stock from the company.

Roughly $93 million of the $180 million program was still untapped as of May 31, 2026. Against a market capitalization of about $618 million (data as of August 1, 2026), that is a dilution reserve of a good 15 percent.

The proxy statement (DEF 14A) of March 11, 2026 describes a pay component that is rarely tied this plainly to the share price. On June 2, 2025, Chairman and CEO Michael P. Connors received, on top of 103,520 ordinary restricted stock units, a target award of 186,335 performance-based restricted stock units. The payout depends on the stock price, measured as an average over 45 trading days ending on the third anniversary of the grant — that is, through June 2, 2028: a target price of $5.00 pays 100 percent, $6.00 pays 150 percent, and $7.00 or above pays the maximum of 200 percent, with straight-line interpolation in between. Anything below that is forfeited outright.

Two things follow. First, the top rung is set high at $7.00 — 372,670 shares would then be worth roughly $2.6 million, close to 30 percent of the entire 2025 net income. Second, it puts a date on the calendar at which management and shareholder interests are unusually well aligned. For completeness: the same chief executive sold 493,703 of his own shares in November 2025 at prices between $5.21 and $5.47.

The insider filings (Form 4) of Information Services Group tell a one-sided story for the twelve months to June 2026. Chairman and CEO Michael P. Connors, who co-founded the firm in 2006, sold 493,703 shares in four tranches between November 7 and 12, 2025 at prices between $5.21 and $5.47 — roughly $2.64 million in total. The filing gives the reason as "estate planning and tax purposes" and points to a Form 144 filed on November 6, 2025; the box for a pre-arranged Rule 10b5-1 trading plan is explicitly not checked.

A month later the largest single holder, France-based Chevrillon & Associés, sold 250,000 shares at $6.06 on December 11 and another 200,000 at $5.95 on December 15, 2025 — roughly $2.71 million. Together that is $5.3 million, more than half of the $9.3 million the company earned in 2025. Every other Form 4 in the period is either a grant of stock units (code A) or shares withheld for taxes (code F). No insider made an open-market purchase after June 2025. Both sellers remain heavily invested: Connors still held 5,156,729 shares after the last filing on June 3, 2026, and Chevrillon still held 5,237,495 shares (11.0 percent) as of February 25, 2026.

The quarterly report (10-Q) as of March 31, 2026 places two receivable disputes right next to each other, and the second one is the uncomfortable one. First: a former client that had engaged the firm for two multi-year projects in 2021 and 2022 stopped paying; on September 3, 2025 a court issued a final, non-appealable judgment awarding Information Services Group roughly $5.6 million plus 5 percent interest per annum. No assets of the debtor had been identified as of the reporting date. A remaining reserve of $1.3 million still sits against the older project.

The second case is new and uncovered: the company is suing another client for the full outstanding balance of $4.7 million — and states verbatim that as of March 31, 2026 it has "not recorded material reserves against this balance." For scale: total net income for 2025 was $9.3 million. Writing off this single receivable would cost roughly half a year of earnings, at an advisory firm whose revenue has not grown in three years.

In 2025 Standard Motor Products paid $27.3 million in dividends to its own shareholders. In the same year the business generated $57.4 million of operating cash flow, of which $38.7 million went into capital expenditures — leaving roughly $18.7 million. The annual report explains the roughly $8.6 million gap without hedging: the dividend was "funded with net borrowings under our 2024 Credit Agreement and cash provided by our operating activities."

The pattern continued into the first quarter of 2026: against a $41.9 million operating cash outflow stood $7.3 million of dividends and $6.7 million of capital expenditures, financed in part by $47.5 million of additional borrowings. In February 2026 the quarterly dividend was nevertheless raised from $0.31 to $0.33 per share. The buyback program, meanwhile, sits idle: of the $30 million authorized in 2022, $19.6 million remained available as of March 31, 2026, with the last purchase made in 2024.

In its first-quarter 2026 earnings release, Standard Motor Products puts two numbers in a single passage: net debt stood at $599.4 million as of March 31, 2026, leverage rose seasonally "modestly to 3.0x" — and the company reiterates its target of getting to 2.0 times adjusted EBITDA by the end of 2026. That is not an analyst wish; it is a publicly stated marker with a date attached.

The arithmetic behind it is demanding. The same release guides to sales growth only in the low to mid-single digit range for 2026 and to an adjusted EBITDA margin of 11 to 12 percent. Take roughly $200 million of adjusted EBITDA from that and the target implies net debt of about $400 million — meaning roughly $200 million of net debt would have to disappear within nine months, while in the prior year $27.3 million of dividends alone were funded partly with borrowings. For context: total debt rose during the first quarter of 2026 from $618.7 million to $658.6 million.

Standard Motor Products bought the brake business in 1986 and sold it again in March 1998. Since September 2001 the company has contractually carried every newly filed asbestos claim itself. As of March 31, 2026, 1,032 cases were outstanding, and roughly $108.1 million had been paid for settlements and damages — with, according to the quarterly report, no insurance coverage at all for indemnity and defense costs.

What stands out is the direction of travel. The actuarial study is performed in the third quarter of each year; the version dated August 31, 2025 raised the estimated range of future payments to $127.5 million to $275.9 million through 2065 — the low end by $27.9 million and the high end by $65.1 million against the prior-year study. SMP accrued the low end in September 2025 and charged earnings with a $44.4 million incremental pre-tax provision. Estimated legal costs of $48.5 million to $115.3 million through 2065 sit on top and are expensed as incurred. Measured against a market cap of roughly $867 million (as of August 1, 2026), the high end of the range equals roughly 32 percent of the company's market value — around 45 percent together with the estimated legal costs.

The annual report for 2025 contains a separate set of accounts for the parent company alone — the so-called Schedule I. It is not there out of a love of transparency but because the rules force it: the restricted net assets of the subsidiaries exceed 25 percent of consolidated net assets. Those accounts show a figure you read twice at a group with more than twelve billion dollars of total assets: as of December 31, 2025 the parent company on its own held $0 of current assets.

How that parent intends to pay its development and administrative costs, it states itself: with the cash on hand, with “the services fee due in September 2026” and with the sale of further equity or debt securities — coupled with the express warning that such a sale may not succeed and, if it does, may be neither cheap nor free of dilution. That services fee is quantified: at the final investment decision for Train 4 the project company Train 4 LLC paid a total of $98 million to NextDecade LLC ($48 million of development fee plus $50 million of services fee), and a further $50 million falls due in September 2026. Measured against the $83,678 thousand of unrestricted cash as of June 30, 2026, that is the largest predictable single item of group liquidity this year.

In the balance sheet as of December 31, 2025 the line for finance lease right-of-use assets showed not a single dollar. Six months later, as of June 30, 2026, it shows $434,079 thousand — right-of-use assets covering LNG carriers. On the other side of the balance sheet sit roughly $430.1 million of lease liabilities, $33,409 thousand of them current. For scale: measured against the market value of roughly $1.79 billion (266,185,433 shares as of July 24, 2026 times $6.73, data as of July 31, 2026), this single line equals about a quarter of the company's entire market valuation — and it appeared within one half-year.

And it will grow. The company announces further charter agreements as the vessels are delivered in the second half of 2026 and is subchartering capacity itself for the first time. So the fleet is complete before the first drop of LNG has been sold: first gas is expected in the second half of 2026, first LNG production from Train 1 in the first half of 2027. It already costs money — in the first half of 2026 the lease liabilities alone carried $5,073 thousand of interest.

On June 10, 2026 nine entities from the General Atlantic and Atlantic Park orbit reported a stake of 16,658,563 shares, or 5.9 percent, of NextDecade in an ownership filing (SCHEDULE 13D). The remarkable part: not one of them is a share. The reported position consists of 8,272,308 exchange shares from convertible Series A loans with $78,586,925 outstanding (exchange price $9.50 per share) plus 8,386,255 warrants. Accordingly the filing does not compute its percentage against the shares actually outstanding but against an inflated base of 281,651,550 shares — the 264,992,987 shares reported as outstanding on May 8, 2026 “plus (ii) 8,272,308 shares of common stock issuable upon the conversion of the Convertible Loans and (iii) 8,386,255 shares of common stock issuable upon the exercise of the Warrants”. Anyone reading only the percentage takes a lender for a major shareholder.

The second half of the filing explains why the construction pays off anyway. Under Item 6 of the ownership filing the holder may designate a director as soon as its exposure from exchange shares and the original principal of the loans together exceeds $150,000,000. The right has already been used: on June 3, 2026 Matthew Bonanno, a managing director at General Atlantic, was elected to the board — with 145,611,322 votes in favor, 449,300 against and a striking 51,873,852 abstentions. Economically the position is under water so far: every exercise right sits at $7.15, $9.30 and $9.50, above the only price documented in a filing, $8.50 on May 12, 2026.

The largest outside shareholder of Ethos Technologies is GV — the venture capital arm of Alphabet, Google's parent company. GV reports to the U.S. securities regulator, the SEC, as a 10 percent owner. Since May 14, 2026 a recurring pattern runs through the Form 4 filings: the fund vehicle GV 2019, L.P. distributes blocks of shares in kind to its partners, and the Alphabet subsidiary Alphabet Holdings LLC sells them on the same day or the next.

The filings document the sale prices: $23.01 to $24.27 in mid-May 2026, and $18.90 to $19.72 between July 21 and July 28, 2026. After the filing of July 29, 2026 the 2019 partnership still held 2,443,425 shares, with another 571,907 held through GV 2021, L.P. — together roughly 3.0 million shares, or 9.8 percent of all Class A shares. The IPO lock-up ran 180 days from the prospectus date of January 29, 2026, but included early releases if the price closed 25 percent above the $19.00 offering price on five out of ten trading days. Anyone following the stock should know that a willing seller holding a high single-digit percentage stake is in the market.

On July 8, 2026, chief executive Peter Colis and president Lingke Wang, the two co-founders of Ethos Technologies, each received a grant of 900,000 restricted stock units. Two Form 4 insider filings reported it on July 10, 2026. Together that is 1.8 million shares — roughly 2.9 percent of all 62,994,262 shares of both classes outstanding as of April 30, 2026, and roughly 5.8 percent of the 30,914,997 publicly traded Class A shares.

The scale becomes clear only against earnings: at a share price around $20, the two packages are worth about $36 million — roughly half of the entire net income for fiscal 2025 ($71.2 million). The awards vest 55 percent on February 15, 2027, then in quarterly steps. The timing is notable: the company had already booked $193.3 million of stock-based compensation expense in the first quarter of 2026, when 5.7 million deferred units vested at the IPO. The next wave of expense now has a date.

The quarterly report (Form 10-Q) as of March 31, 2026 shows net income for the first time: $81.4 million. The line immediately below shows the split — $39.6 million was attributable to non-controlling interests, leaving $41.7 million for Ivanhoe Electric shareholders. The reason lies in where the money came from: the entire gain arose from the sale of the Alacran project by majority-owned subsidiary Cordoba Minerals (gain on divestment of $124.7 million), in which JCHX held 19.2 percent as of December 31, 2025, among other outside holders.

The cash flow statement is even more explicit. Of the $124.8 million of proceeds, Cordoba paid $12.2 million of income taxes and distributed $40.1 million in cash to its non-controlling shareholders. Together that is roughly 42 percent of the proceeds leaving the group immediately — the $40.1 million alone equals 13.8 percent of cash on hand at March 31, 2026. The headline "first profit" therefore describes an event of which a substantial share never reached an Ivanhoe Electric shareholder.

The senior secured $200.0 million credit facility for the Santa Cruz mine, closed in December 2025, carries a condition that appears only as a subordinate clause in the quarterly report (Form 10-Q) as of March 31, 2026: Ivanhoe Electric guarantees the payment obligations of its subsidiary Mesa Cobre and agrees to maintain at all times a tangible net worth of not less than $225.0 million. Alongside it come a first priority lien on substantially all of Mesa Cobre's assets, a pledge of the Mesa Cobre shares and a deed of trust over its real property rights.

The cushion is comfortable today, but it shrinks. Equity attributable to common stockholders stood at $540.3 million as of March 31, 2026 — the $225 million threshold equals roughly 42 percent of that. Against it stand $42.3 million of operating cash outflow in the first quarter of 2026 alone and a purchase agreement signed May 28, 2026 for a tunnel boring machine at $64,710,043. Without new equity the threshold would arithmetically come into view within a few years — and the closer it gets, the less free the choice between issuing shares and hitting the brakes.

The notes to the quarterly report (Form 10-Q) as of March 31, 2026 contain a number that appears in no press release. Subsidiary VRB Energy issued a convertible bond on July 8, 2021 for gross proceeds of $24.0 million, with a five-year term and interest accruing at 8 percent per year. As of March 31, 2026 the balance of principal and accrued interest stood at $34.5 million, classified on the balance sheet as a current liability. The filing spells out the condition in plain language: unless an equity financing, a sale event or another agreed restructuring with the bondholder occurs, VRB Energy must repay principal and interest at maturity in July 2026.

The scale matters: $34.5 million equals roughly 71 percent of all consolidated liabilities ($48.6 million as of March 31, 2026) and about 12 percent of cash. Through the most recent filing before the data cutoff for this research — the conflict minerals report (Form SD) dated July 10, 2026 — the company has filed no current report (Form 8-K) describing repayment, conversion or extension. The energy storage segment, which includes VRB, carried segment assets of $55.6 million as of March 31, 2026. How this ends will first appear in the next quarterly report.

Alongside the ordinary Class A share (METC), a second class trades on Nasdaq: Class B (METCB), roughly 11.37 million shares as of May 8, 2026 and therefore about 17 percent of all Ramaco shares. It is marketed as an interest in the internal unit "CORE," which is credited with infrastructure fees of $5.00 per ton of coal processed and $2.50 per ton loaded, plus future income from rare earths and critical minerals. The quarterly report states the legal position plainly: "CORE is not a separate legal entity, and holders of Class B common stock do not own a direct interest in the assets of CORE."

It goes on to say that the board of directors retains the power to change the expense allocation for CORE, to redefine the assets attributed to CORE and to reset the per-ton usage fees at any time, in its sole discretion and without shareholder approval. In addition, the board may exchange all outstanding Class B shares into Class A shares at its discretion, at a ratio based on a 20-day trailing volume-weighted average price of each class. The Class B dividend is paid in Class B shares and is shrinking: $0.1489 per share for the first quarter of 2026 and $0.1369 for the second (payable June 26, 2026). Anyone buying METCB as a pure rare earth instrument is buying a share whose economic content the board is free to change.

In November 2025 Ramaco Resources placed a convertible note carrying a 0.0 percent coupon and $345.0 million of principal, maturing on November 1, 2031. The conversion price is roughly $32.74 per Class A share. The quarterly report as of March 31, 2026 contains a fair value disclosure that is rarely quoted: the notes carried an estimated fair value of $253.1 million at that date, down from $292.9 million at December 31, 2025. That is $39.8 million less within a single quarter, and roughly a 27 percent discount to principal.

The valuation is based on publicly traded market prices (a Level 2 measurement), so it is not a company model. And it is informative: a buyer of a zero-coupon note earns only through repayment at par or through conversion into shares. A price of roughly 73 cents on the dollar says the credit market neither expects an early conversion above $32.74 nor treats repayment in 2031 as risk-free — at the same time as a shareholder letter that assigns the main project an $8.0 billion net present value. For comparison: the two interest-bearing notes (8.375 percent due 2029 with $57.5 million of principal, 8.250 percent due 2030 with $65.0 million) were marked at $57.8 million and $65.3 million on the same date, essentially at par.

On July 24, 2026, Ramaco Resources filed two corrections at once. The amended annual report (10-K/A) for 2025 lists nine changes, among them the verbatim item "to remove statements asserting the technical and economic viability of the Company’s Brook Mine rare earth/critical minerals project." The Fluor study of July 2025, until then labelled a "Preliminary Economic Assessment," is now called only the "Fluor Study" and described as a conceptual study that was not prepared in accordance with Subpart 1300 of Regulation S-K. The reason sits in the closing sentence of the section: "The foregoing revisions were made in response to comments from the staff of the Commission."

The same day, an amended current report (8-K/A) replaced the shareholder letter of September 18, 2025 with a version from which "certain tabulations covering development options, margin analysis, cash flow analysis, valuation, and summary of production metrics" had been removed. The original SEC comment letter is dated August 19, 2025 according to the annual report and concerned the quarterly report for the period ended June 30, 2025; under "Unresolved Staff Comments" Ramaco records that those comments have remained unresolved. The sequence is what stands out: five days after the forced deletion, on July 29, 2026, the company published a new shareholder letter carrying internally prepared estimates of an $8.0 billion net present value — expressly not the output of a study prepared under Subpart 1300.

On January 12, 2026 T3 Defense acquired all of Star 26 Capital Inc. The quarterly report as of March 31, 2026 records: "Mr. Shalom, the Company's Chief Executive Officer and a director, is also a controlling shareholder and director of Star." — the buyer's chief executive and director was at the same time the seller's controlling shareholder and director. The fair value of the consideration transferred was $69.433 million per the purchase price allocation. Of that, $72.255 million is goodwill; the net tangible assets acquired were negative $3.702 million. The intangibles that are being amortized added up to $0.237 million (customer relationships $31 thousand, distributor relations $16 thousand, order backlog $190 thousand); alongside them the same purchase price allocation carries $0.905 million of intangible assets classified as available for sale.

For context: through its subsidiary Rimon, Star 26 contributed $1.601 million of revenue in the first quarter of 2026, and Rimon employs 18 people per the annual report. Total goodwill on the balance sheet rose from $7.688 million (December 31, 2025) to $100.150 million (March 31, 2026) against equity of $42.523 million. Goodwill is the line that gets written down first when the annual impairment test comes around.

In October 2024 the company, then still Nukkleus Inc., reverse split its stock 1-for-8 — the risk factor in the annual report gives October 11, 2024 as the effective date, the notes give October 24, 2024 as the date the charter was amended. On July 20, 2026 T3 Defense followed with 1-for-125, a cumulative 1,000-to-1 within 21 months. Its own annual report for 2025 spells out what that means: under Nasdaq Rule 5810(c)(3)(A)(iv) a company gets no compliance period at all if the price fails the $1.00 threshold (A) within one year of a reverse split becoming effective or (B) if the company has carried out reverse splits with a cumulative ratio of 250-to-1 or more over the prior two years. The exchange then issues a staff delisting determination immediately.

Of the two, condition (B) has applied since July 20, 2026: 1-for-8 times 1-for-125 is 1,000-to-1, far above the 250-to-1 threshold. Condition (A) is not a state but a trigger — it bites the moment the closing price slips back below a dollar within one year of the split becoming effective, that is, through July 20, 2027. And (B) expires first: once the 1-for-8 split drops out of the two-year window in October 2026, only 125-to-1 is left — less than the required 250-to-1. From then on (A) carries it alone. The running deadline from the May 5, 2026 notice (compliance by November 2, 2026) is therefore not the real date — the real date is every single trading day through July 20, 2027 on which the closing price could slip below a dollar. For investors this is not a valuation argument but a venue risk: per the same annual report, a delisting would among other things trigger debt acceleration and breach acquisition agreements.

On April 15, 2026 T3 Defense published a results release (8-K, Item 2.02) with preliminary first-quarter 2026 figures: "Expects Q1 2026 Revenue to be Approximately $4.2 Million," alongside a backlog of $12.1 million as of March 31, 2026 and reaffirmed full-year guidance of $26 million. Five weeks later, on May 20, 2026, the quarterly report (10-Q) for the same quarter reported $3.653 million — roughly 13 percent below the guided figure.

What happened next is the notable part: the prospectus 424B3 dated June 30, 2026 and filed July 1, 2026 — six weeks after the quarterly report — still repeats the old numbers verbatim: "there was $4.2 million in revenue, a backlog of $12.1 million, and a $26 million full-year revenue projection." The full-year figure is the sharper test: to reach $26 million, quarters two through four together have to deliver $22.3 million — an average of $7.4 million per quarter, roughly double the first quarter.

At the annual meeting on August 5, 2026, T3 Defense shareholders vote on the "2026 Evergreen Equity Incentive Plan" — a share-based compensation plan with an initial pool of 22,000,000 shares that, per the proxy statement of July 9, 2026, automatically grows by 8 percent every year from August 1, 2027 through 2036. What makes it interesting is two supplements filed two days apart. On July 14, 2026 the company said the 22 million shares would not be adjusted for the upcoming reverse split — against 1,010,495 shares outstanding after the split, the plan would have covered roughly twenty times the entire company. On July 16, 2026 the company withdrew that supplement and corrected the figure to 176,000 shares.

Even the corrected number is large: 176,000 shares equal roughly 17.4 percent of the 1,010,495 shares the ownership filing of July 24, 2026 reports as of July 6, 2026 — and the pool then grows 8 percent a year. For investors this is a hard calendar question: if the plan passes on August 5, 2026, a sixth of the company is reserved for compensation before the first contract has been delivered.

In August 2025 Equillium announced it would widen its own treasury strategy to include digital currencies and amended its internal investment policy accordingly. The annual report for 2025 says in the same breath: "We have not initiated our cryptocurrency treasury strategy" — so nothing has actually been done. Through July 30, 2026 no filing shows any execution: the balance sheet as of March 31, 2026 carries no line for digital assets, and the asset side consists of $61.322 million of cash and $953 thousand of prepaid expenses.

What is interesting is where the money would come from. Only the proceeds of the two private placements are expressly excluded from crypto use — the proceeds of the $75.0 million at-the-market sales facility for ongoing share sales over the exchange may, per the risk chapter, flow into cryptocurrencies. That facility is close to untouched so far: since inception 1,719,485 shares were sold for gross proceeds of $1.0 million, and not a single one in the first quarter of 2026. For scale: the crypto risk chapter in the annual report runs to roughly 25,500 characters, the description of both compounds to roughly 10,900 — more than twice as much about cryptocurrency as about the actual product.

The annual meeting of May 28, 2026 passed two resolutions that could not possibly appear in the quarterly report filed on May 13, 2026. First: authorized capital was doubled from 200,000,000 to 400,000,000 shares — and not merely approved but already executed the same day by certificate of amendment. Second: the board may carry out a reverse stock split of 1-for-2 up to 1-for-20; whether at all, when and at which ratio rests, per the resolution text, in its sole discretion. According to the proxy statement that authority runs through December 31, 2027.

Two things stand out. First the resistance: on the capital increase 11,570,307 shares voted against — roughly 21 percent of the 54,287,329 shares represented at the meeting, while opposition on the other substantive resolutions stayed below 3 percent. Second the occasion: the Nasdaq minimum bid price requirement that could force a reverse split has been satisfied since August 29, 2025; there is no open listing proceeding. The authority is therefore a cosmetic tool held on standby — and the doubled capital authorization makes room for far more shares than exist today: 63,226,556 outstanding plus 101,477,921 reserved add up to 164,704,477 potential shares.

The private placement of August 2025 contains a clause that shows up nowhere in the share price: the investors have committed to buy, at a so-called milestone closing, up to 35,087,717 additional shares (or pre-funded warrants instead) — at the original price of $0.57 per share, for gross proceeds of up to roughly $20.0 million. Two things have to happen. First, clearance of the clinical trial application for EQ504 or the first dosing of a subject in a SAD/MAD study in Australia or New Zealand, in either case before August 10, 2030. Second, a volume-weighted average price of at least $2.50 over 10 consecutive trading days within the 30 trading days following the milestone announcement — or a waiver of that price threshold by a majority of the investors.

The sting is the fixed price: the issue price stays at $0.57 no matter where the stock trades when the trigger fires. Measured against the documented insider sale price of June 4, 2026 (average $3.1638) that would be a discount of roughly 82 percent. Measured against the 63,226,556 shares outstanding (May 8, 2026) it would add a good 55 percent more stock. For a company without revenue, the good news is therefore also the most expensive one: success in the first clinical study is the starting gun for the sharpest dilution clause on the books.

Note 12 of the quarterly report (10-Q) as of March 31, 2026 contains a clause that is easy to skip — and it appears there twice. If the company completes a change-of-control transaction in which its enterprise value is $500 million or greater, then 5,804,286 of the “Merger Options” granted in connection with the deal vest in full at once — and so do all 6,108,470 “Founder RSUs” held by the co-founders of the acquired business. Together, 11,912,756 shares.

The order of magnitude is the point: 11.9 million shares equal 43.1 percent of the 27,635,745 common shares outstanding on July 8, 2026. And the $500 million threshold sits below the value the company already carries in the market — 27,635,745 shares at the last price documented in a filing, $16.50 on July 8, 2026 (prospectus 424B7), come to roughly $456 million, and roughly $933 million once all the preferred converts. The trigger is therefore not a distant scenario but a mark that a sale of the company would almost inevitably clear.

The 424B7 prospectus of July 22, 2026 registers 53,390,008 common shares for resale by the former owners of the acquired business. The document does the math itself: if all of those shares were outstanding, they would represent roughly 94 percent of all common stock. As of July 8, 2026 there were 27,635,745 shares outstanding, held by exactly 77 holders of record.

The second half of the finding sits in the merger Form 8-K of March 19, 2026: directors, officers and substantially all former owners signed lock-up agreements and may not transfer their shares “until 180 days following the Closing.” Counted from the March 19, 2026 closing, that period runs to mid-September 2026. Put together: the resale registration is finished and on file exactly when the lock-up runs out.

The notes to the quarterly report (10-Q) as of March 31, 2026 carry a loan that is small in size and yet describes an existential question for an entire segment. On August 6, 2025 Movano borrowed $1.5 million from Evie Holdings LLC, a related party. After three amendments the deal reads as follows: if the old healthcare business is sold, $1.5 million of principal plus a $3.0 million repayment premium plus the sale proceeds become due. If it is not sold, the legacy assets pass to the lender on the maturity date “in full satisfaction of the debt.” The maturity date was June 30, 2026. The loan carried a $4.5 million balance as of March 31, 2026 — 15.4 percent of the $29.3 million of cash held at the time.

The name is the notable part: “Evie” is the brand name of the very wellness ring at issue. So is the gap: none of the filings through July 22, 2026 — not the Forms 8-K of June 16, June 26 and July 7, not the S-1 of July 10, not the 424B7 prospectus of July 22 — says what happened on June 30, 2026. The next quarterly report has to show whether the loan was repaid, the segment sold, or the assets handed to the lender.

In the annual report 20-F for 2025 management states that internal control over financial reporting was not effective as of December 31, 2025: "Management identified material weaknesses in controls over inventory, payroll and accounts payable." The same report spells out the result of testing six control areas during 2025: cash, equity, payroll and financial reporting worked, while material weaknesses remained "in controls over procurement to pay and inventory management and counts." The MD&A for the first quarter of 2026 repeats that finding and records that internal control did not change during the quarter.

What makes this interesting is the balance sheet: inventories rose from $796 thousand (December 31, 2024) to $3,891 thousand (December 31, 2025) and to $5,536 thousand (March 31, 2026) — almost sevenfold in fifteen months, reaching 8.1 percent of equity. The fastest-growing balance sheet item sits precisely in the area the company itself describes as inadequately controlled. In fairness: a new enterprise resource planning system has been live since January 1, 2026 and additional staff has been hired.

On January 7, 2026 the board of A2Z Cust2Mate approved a buyback of up to $20 million of its own shares. Through July 6, 2026 it had purchased 1,066,541 shares for $6,668,473, with roughly $13.3 million still available; the program runs to December 31, 2026. The stated reason: the market price does not adequately reflect "the Company's underlying value and prospects."

Eleven weeks before that extension, on April 17, 2026, the same company filed a shelf registration (Form F-3) that has been effective since May 14, 2026 and permits the sale of securities of up to $200 million — roughly 76 percent of the market value of about $263 million (data as of July 30, 2026) and almost three times the $68.646 million of equity as of March 31, 2026. On top of that sit 5,163,571 outstanding options and warrants against 45,075,009 shares (as of May 14, 2026), another 11.5 percent. One hand is shrinking the share count; the other has secured permission to raise it substantially.

Between June 17, 2025 and April 30, 2026 A2Z Cust2Mate announced five quantified orders and framework agreements: Yochananof $55 million for 5,000 carts, Carrefour Israel about $50 million for 4,000 carts, Trixo for Mexico and Central America more than $25 million for 3,000 carts, Toys "R" Us Israel and The Red Pirate at least $15 million for 2,000 carts, HaStock more than $21 million for 2,000 carts. Total: roughly $166 million, plus the Turkish announcement with Migros Ticaret carrying no figure at all. Consolidated revenue for the twelve months through March 31, 2026 was $9.671 million — the order book is therefore about seventeen times one year of revenue.

The interim report as of March 31, 2026 names three hard dates against which this can be checked, and all three fall in the same quarter: the Carrefour rollout "is set to begin in the third quarter of 2026 across six Carrefour Israel flagship stores," the HaStock deployment begins "in Q3 2026" at three stores in Haifa, Beer Sheba and Petach Tikva, and for the 2,000 carts ordered by Toys "R" Us Israel and The Red Pirate "Deployment is scheduled to commence Q3, 2026." Most recently the smart-cart segment contributed $2.450 million of quarterly revenue (Q1 2026), against gross profit of $139 thousand at group level. If you want to know whether announcements turn into revenue, that is the line to read in the next interim report.

The annual report (10-K) for 2025 contains a number that looks oddly large next to Hour Loop's tiny free float: as of March 24, 2026, 9,152,213 shares were still available for issuance under the 2021 equity incentive plan. That is 26 percent of the 35,191,890 shares outstanding (as of May 12, 2026) — and several times the roughly 1.8 million shares that actually trade, because the founding couple holds 33,360,142 of them.

There is an automatic ratchet as well: the filing says the plan is increased every January 1 by the lesser of 3 percent of the shares outstanding at the preceding year end or an amount set by the board — on current numbers, up to a little over a million shares a year. So far the reserve has been used sparingly: in 2025 the company issued 1,596, 1,750, 2,275 and 951 shares per quarter to five individuals, and in 2026 it issued 1,514 shares each on January 5, 1,600 each on April 6 and 1,586 each on July 1 (five insider filings (Form 4) dated July 2, 2026). That restraint is precisely the point. Anyone buying into a 5 percent float should know that five times that amount could be issued at any time — your slice of the cake gets smaller when new slices keep being cut.

The proxy statement for the 2026 annual meeting (filed June 25, 2026) lists the pay of the company's only two executives: Sam Lai, $1,118,218 ($500,000 in salary, $600,000 in bonus, $18,218 in other compensation) and Maggie Yu, $1,019,774 ($450,000, $550,000, $19,774). Together that is $2,137,992 — against net income of $1,704,849 for the same year. The married couple cost a quarter more than the business earned.

The bonus mechanics were rewritten on May 15, 2026 (Form 8-K of May 18, 2026): if Hour Loop reaches profits "excluding taxes and executives' bonuses" of at least $1,000,000, each receives 50 percent of base salary; at $2,000,000 it becomes 100 percent. The measure is therefore a figure the company does not publish — and one that excludes the bonuses themselves. Separately, each is entitled to a guaranteed $100,000 bonus on December 22, 2026. Because the couple controls 94.8 percent of the votes, no one but the two of them effectively decides on those contracts.

Buried under "Subsequent Events" in Hour Loop's quarterly report (10-Q) for the period ended March 31, 2026 is the sentence that explains the company's entire liquidity position. Because Amazon delayed its daily remittances by seven days, Chairman and CEO Sam Lai and Senior Vice President Maggie Yu together advanced $1,601,000 to the company in April 2026 — and the filing adds: "At present, no formal contract has been entered into." No contract, no interest rate, no maturity.

The size matters. That advance equals 20 percent of shareholders' equity ($7,814,724 at March 31, 2026) and 1.6 times the entire cash balance ($992,886 on the same date). Formally reported related-party liabilities stood at $2,060,418 at quarter end; add the April advance and the founders are funding roughly $3.66 million of working capital. A Nasdaq-listed company with $142 million of annual revenue whose working capital hangs on the executives' personal accounts is a finding in its own right — and the next question is already set: will the advance be documented, priced, converted into equity, or repaid?

When DMC bought 60 percent of Arcadia Products in December 2021 it did something you rarely see on a balance sheet: the company lent money to the seller. The notes to the quarterly report as of June 30, 2026 give both the amount and the reason: $24.902 million, advanced immediately after closing in order to equalize the after-tax consideration to the minority holder relative to an alternative transaction structure. The loan is unsecured and sits in the balance sheet under "Other assets".

Repayment is tied to exactly the event this whole company revolves around: it comes out of the proceeds from the sale of the minority holder's Arcadia interests — whether on exercise of the put option, the call option or a permitted sale to third parties — and must be repaid in full no later than December 16, 2051. In practice that means DMC would only pay the difference out of the $187.08 million floor price. Measured against a market value of roughly $111 million (as of July 29, 2026), those $24.9 million are more than a fifth — and they depend on the solvency of the very same counterparty.

The SCHEDULE 13D/A filed on February 24, 2026 by the investor group around Steel Partners Holdings L.P. contains two numbers that have to be read together. First the position: 1,194,441 shares held directly by Steel Connect Sub LLC, or 5.8 percent of the 20,590,482 shares outstanding at the time. Second the cost: the aggregate purchase price of those shares was approximately $20,994,267, including brokerage commissions.

Divide one by the other and the average entry price works out to roughly $17.58 per share (our own calculation from the two reported figures). For comparison, the closing price on July 29, 2026 was $5.42. An activist sitting on a paper loss of roughly two thirds has a very different sense of urgency than an index fund — and the Arcadia minority holder's put window, open from September 6, 2026, offers a natural stage. What matters for investors is therefore less the position itself than any change to it.

On June 5, 2024 DMC Global adopted a Stockholder Protection Rights Agreement — a poison pill in market shorthand. It works like this: once anyone (alone or acting as a group) accumulates more than 10 percent of the shares — 20 percent for certain passive investors — every other holder may buy $150 worth of stock for $75. The acquirer may not, so his stake is diluted away. The unusual part is not the pill itself but its history of extensions: twice, by one year each time, most recently on April 24, 2026, out to June 4, 2027.

The Form 8-K explains why this is more than housekeeping. It states that beneficial ownership continues to include securities as to which a person has "a right to become the beneficial owner – including upon exercise of conversion rights". Precisely such a conversion right would come into being if DMC paid for the redeemable 40 percent stake in Arcadia Products (floor value $187.08 million) with the preferred stock the operating agreement permits. The pill therefore points not only at outside buyers but along the fault line inside the company.

The 2025 annual report names the largest client outright: Meta, 26 percent of annual revenue (2024: 22 percent). The quarterly report as of March 31, 2026 gives no name at all, only "Client A" — and that client has fallen to 24 percent of quarterly revenue, down from 26 percent a year earlier. The second row of the same table is even sharper: this client's share of outstanding receivables dropped from 19 percent on December 31, 2025 to 11 percent on March 31, 2026.

On quarterly revenue of $306.3 million, two percentage points are roughly $6 million — a quarter of the $24.3 million quarterly profit. And the context makes the number pointed: the same annual report states that client automation initiatives, "including our largest client", may replace services TaskUs performs today. Whether this is one client simply growing more slowly than the rest or automation already biting will be decided in the next concentration table.

One line in the March 31, 2026 balance sheet is easy to miss: 15,436,224 treasury shares at a cost of $189.3 million. That works out to $12.26 per share — money the company spent on buybacks over the years. For scale: the entire market capitalization stood at roughly $570 million in late July 2026 (data as of July 29, 2026). The treasury holding therefore equals about a third of what the whole company is worth today, and roughly 42 percent of all tradable Class A shares.

What has not happened since is the more interesting part. In the first quarter of 2025 TaskUs still repurchased $9.7 million of its own stock. In the first quarter of 2026 the figure was zero — instead $332.8 million left the company as a special dividend, mostly to the controlling holders, and $500.0 million came in as a new term loan. Anyone who wants to know whether management thinks its own stock is too cheap will find the answer in exactly one line of the cash flow statement.

The TaskUs charter contains an expiry date almost nobody has on their radar. Each Class B share carries ten votes and converts into one Class A share at any time, but "no later than June 10, 2028" — seven years after the charter took effect at the IPO. On that day the leverage disappears: Blackstone and the two co-founders, who held roughly 96.9 percent of the combined voting power as of December 31, 2025, are left with nothing but their economic stake.

For the stock itself the mechanical consequence is bigger than the political one. Only the Class A trades today: 36,545,511 shares as of May 1, 2026. The 55,032,694 Class B shares convert one for one, so the tradable share count rises to 91,578,205, an increase of 151 percent. Nobody is economically diluted — the shares already exist — but index weighting, free float and trading volume all change step-wise. The 2025 annual report names exactly this point as a risk: a change in ownership composition, "including due to the eventual expiration of the ten-to-one voting rights", could materially affect the company's operations and Class A ownership.

Anyone speculating on a second take-private attempt after the failed October 2025 vote now has a date: while the ten-vote shares are still running, a control transaction is materially cheaper for the majority to organize than it will be afterwards.

On June 8, 2026 Mastercard completed a notes offering in five tranches: $500 million of floating rate notes due 2028, $1,250 million of 4.325 percent notes due 2028, $1,150 million of 4.425 percent notes due 2029, $1,350 million of 4.600 percent notes due 2031 and $750 million of 5.000 percent notes due 2036 — $5.0 billion in total. Stated use of proceeds in the prospectus supplement: general corporate purposes.

None of this appears in any periodic report available at press time. As of March 31, 2026 total debt stood at $19.0 billion ($1,748 million short-term, $17,212 million long-term); the new tranches equal 26 percent of that. In addition, $2.5 billion of commercial paper was outstanding as of April 27, 2026 at a weighted-average rate of 3.82 percent, the first drawing since the start of the year. Interest expense was $722 million in 2025; at coupons between 4.325 and 5.000 percent the new notes add roughly $220 million of annual interest.

In March 2026 Mastercard agreed to acquire a 100 percent equity interest in BVNK Holdings Limited, a provider of stablecoin infrastructure, for $1.5 billion plus contingent consideration of up to $300 million. Closing is subject to regulatory approval; Mastercard expects it before the end of 2026. Measured against accounting equity of $6,722 million as of March 31, 2026, the purchase price equals roughly a quarter.

The deal continues a pattern: in December 2024 Mastercard acquired Recorded Future, a threat intelligence company, for $2.7 billion in cash, of which $1.7 billion was booked as goodwill. Three of the 23 percentage points of value-added services growth in 2025 came from acquisitions. Goodwill and other intangible assets totaled $15,020 million as of March 31, 2026 — 29 percent of total assets and more than twice equity. If an acquisition underperforms, the write-down lands directly on that thin equity base.

In the U.S. interchange class actions Mastercard is still litigating with two groups of opt-out merchants. The first comprises six merchants seeking aggregate single damages in excess of $0.5 billion, with trial scheduled to begin in September 2026. The second consists of Block and Intuit, seeking in excess of $5 billion in single damages — for their own volume and that of smaller merchants for whom they acted as payment facilitators. Under U.S. antitrust law single damages can be trebled in a judgment.

Against that stood an accrual of $177 million for the U.S. class actions as of March 31, 2026 (December 31, 2025: $637 million), within total accrued litigation of $339 million (December 31, 2025: $800 million). Unlike Visa, Mastercard has no escrow fund: under the 2011 sharing agreements it pays 12 percent of a global settlement involving the Visa parties and the banks, or 36 percent of a settlement involving only the banks — out of its own income statement. The single damages sought by Block and Intuit equal three times accounting equity.

As of March 31, 2026 Mastercard held 526 million of its own Class A shares, carried in the balance sheet at a cost of $87,342 million and deducted from equity (December 31, 2025: 518 million shares at $83,224 million; December 31, 2024: 497 million at $71,431 million). What remained was total equity of $6,722 million on total assets of $52,449 million — an equity ratio of 12.8 percent. Of 1,406 million Class A shares issued, 37 percent sit in treasury.

Two metrics become unusable as a result: return on equity of 232 percent and a price-to-book ratio of 74 on a book value of $7.58 per share (data as of July 30, 2026). The pace continues: $11,727 million of repurchases in 2025 (21.1 million shares at an average of $555.78) and $4,035 million in the first quarter of 2026 alone (7.8 million shares at $519.67). Remaining authorization fell from $17.5 billion (December 31, 2025) to $11.7 billion (April 27, 2026).

Mastercard's reported payment network net revenue only exists after rebates and incentives to banks, merchants and partners have been deducted. In 2025 that was $20,522 million — set against remaining net revenue of $19,476 million, gross revenue was $39,998 million. The incentive ratio came to 51.3 percent, after 50.4 percent in 2024 ($17,629 million of $34,964 million).

In the first quarter of 2026 it rose to 53.3 percent: $5,639 million of incentives against $4,948 million of net revenue, with incentives up 23 percent versus 12 percent for network net revenue. One percentage point equals roughly $400 million on a 2025 basis, or 2.7 percent of the year's profit. Mastercard names no target; the auditor treats the estimation of this item as a critical audit matter because net revenue may be materially different if expectations about customer performance do not hold.

On April 22, 2026 Heidmar received written notice from Nasdaq: the closing bid price had been below $1.00 for 30 consecutive business days, breaching the minimum bid price requirement of Listing Rule 5550(a)(2). The annual report on Form 20-F for 2025 names the date: "the applicable grace period to regain compliance is 180 days, or until October 19, 2026." The deficiency is cured once the closing bid price is at least $1.00 for ten consecutive business days.

This is a rare case of a genuinely binary event with a calendar date. Three outcomes are possible. The price recovers on its own — the last closing price documented in a filing was $1.14 on May 28, 2026, just above the line. Or the company applies for a second 180-day period. Or it resolves on a reverse split, which consolidates the share count and lifts the price arithmetically. A reverse split changes nothing about the value of the business, but it tends to shape the subsequent price path, and with a float of only 6,498,572 shares (May 20, 2026) it would tighten tradability further. Each of those decisions would first appear in an interim report on Form 6-K.

Heidmar pools depend on third-party owners entering their ships. The annual report on Form 20-F for 2025 spells out how narrow that base is in its risk factors: "The Capital vessels compose 25 of the 49 vessels currently managed by Heidmar and accounted for 37% of our total revenues from the Pools during the year ended December 31, 2025." The reference is to Capital Maritime and Trading Corp. — and the same paragraph says who owns it: "Capital is owned by the father of the indirect owner of Maistros Shipinvest Corp., one of our major shareholders." Maistros holds 26,238,379 Heidmar shares, or 44.5 percent, as of April 29, 2026.

More than half the pool fleet and more than a third of pool revenue therefore rest with a single shipowning family that is at the same time a co-owner of the manager. The report names the consequence itself: a withdrawal by Capital would have "a material adverse effect on our business". The numbers are already moving. The average number of vessels in the pools fell from 30.0 (2024) to 18.0 (2025), pool days from 10,792 to 6,608, and fee income from pool management dropped from $9.76 million to $7.91 million. The 2025 related-party table shows $333,792 of management fees and $1,254,034 of commissions for the Capital vessels.

One item towers over the December 31, 2025 balance sheet: a right-of-use asset from an operating lease with a related party of $40,279,432 — 56 percent of the $72.14 million balance sheet total. Behind it sits a single vessel. In April 2025 Heidmar chartered in the platform supply vessel ACE Supplier for an initial term of five years with three one-year extension options. Per the notes, the owner is a company owned by the ultimate beneficial owner of one of the principal shareholders. The right-of-use asset and lease liability were initially recognized at $45,913,646.

The matching obligation is carried at $8,242,105 current and $32,037,327 non-current — $40.28 million together, and close to four times the $10.71 million of shareholders equity at the same date. What the vessel earns is modest by comparison: the notes show a 2025 charter-in expense of $7,824,362 against charter-out revenue from the same vessel of $8,075,520 — a surplus of $251,158, or 3.1 percent. For investors that is a hard question: a multi-year obligation of roughly $40 million entered into with a related party, which produced a quarter of a million dollars in its first year. If the sub-charter falls away, the hire is still due.

On June 6, 2025 Heidmar signed a common shares purchase agreement with B. Riley Principal Capital II LLC: at its own discretion the company may sell up to $20 million of its shares to the counterparty. The prospectus supplement filed on June 1, 2026 registers 11,080,332 shares for resale. That number only becomes interesting next to the float: 58,991,997 shares were outstanding on May 20, 2026, of which just 6,498,572 were held by non-affiliates. The registered resale volume therefore equals roughly 1.7 times the entire freely tradable stock.

Very little of the line has been drawn so far. Through March 31, 2026 Heidmar had sold only 260,628 shares at an average of $1.27, for gross proceeds of about $330,940 — 2.4 percent of the registered amount. That is exactly where the trade sits: the prospectus itself calculates that full use would leave 70,072,329 shares outstanding, and states plainly that going beyond that amount could cause "additional substantial dilution". Anyone watching the stock should check the reported share count in every new prospectus supplement and every interim report on Form 6-K — it is the most direct read on how fast Heidmar is drawing the line.

Carriage Services grew revenue by $13.2 million, or 3.3 percent, to $417.4 million in 2025. Receivables grew by $26.6 million in the same year: ordinary accounts receivable from $30.2 million to $40.6 million (up 34.6 percent), preneed cemetery receivables from $51.0 million to $67.1 million (up 31.6 percent). In percentage terms, receivables grew roughly ten times faster than revenue.

The reason is the business model: cemetery property is sold during a customer's lifetime and paid in installments, so revenue is booked well before the cash arrives. The 2025 cash flow statement accordingly shows an outflow of $28.151 million in the line for accounts and preneed receivables (2024: $24.620 million; 2023: only $8.122 million). That is why free cash flow of $40.1 million in 2025 sat below the $57.6 million of 2023, even though net income had risen from $33.4 million to $51.5 million. Read the profit line and you see a record. Read the cash line and you see a step back.

Two things happened at the annual meeting on May 12, 2026 that are usually a formality. First: extending the 2017 equity incentive plan by five years — a pure deadline extension to May 13, 2031, with no new shares — passed by 6,138,408 votes to 5,843,510. That is 51.2 percent to 48.8 percent. Almost half the votes cast wanted the plan to lapse. Under that plan, the May 6, 2026 prospectus supplement lists 2,707,421 shares still reserved for future issuance — 17.1 percent of the 15,872,328 shares outstanding.

Second: the proposal to declassify the board and stand every director for annual election drew 11,975,332 votes for and 16,360 against — near unanimity. It failed anyway, because the certificate of incorporation requires 80 percent of all outstanding shares and 1,854,346 broker non-votes were never cast at all. A reform that 99.8 percent of voters wanted broke on the company's own threshold.

Carriage Services holds 11,627,818 shares in treasury, acquired for $278.753 million — an average of $23.97 per share (balance sheet as of March 31, 2026). That is the result of years of repurchases. The machine has since been switched off: the 10-K for 2025 states that not a single share was repurchased in 2023, 2024 or 2025, while $48.9 million of authorization remains open.

On May 6, 2026, the flow reversed. Under an equity distribution agreement with Oppenheimer & Co. and Raymond James, the company may now sell new shares worth up to $100 million directly into the market — up to 2,115,954 shares by the prospectus supplement's own math, or 13.3 percent on top of the 15,872,328 shares outstanding. The price used for that calculation: $47.26, the last reported sale price on May 4, 2026. Repurchasing at an average of $23.97 and issuing near $47 is not bad capital allocation — but both authorizations now stand open at the same time, and the agreement obliges the company to report actual sales at least quarterly. That number is the test.

Looking for the anchor shareholder of a NYSE-listed crude oil shipping group, you would expect a family clan, a sovereign wealth fund or a private equity firm. At Teekay, the chain ends at a charity. Schedule 13D/A No. 15, filed May 28, 2026, reports Resolute Investments, Ltd. with 31,936,012 shares, or 36.71 percent. Resolute is wholly owned by Kattegat Limited, which in turn is wholly owned by The Kattegat Trust — described in the filing as "a Bermudian charitable trust, engaged in the principal business of distributing income for charitable purposes."

That explains a good deal about capital policy: a trust that has to distribute income needs distributable income — and Teekay declared a special dividend of $1.00 per share in 2024, 2025 and 2026. Of the $87.4 million paid in June 2026, roughly $31.9 million went to the trust. The reason for the filing is telling as well: the trust did not sell a single share. Its percentage fell purely because the total share count rose through option exercises — the filing names exactly that as the cause. The anchor shareholder is being diluted passively.

On October 30, 2024, Teekay's board authorized a share repurchase program of $40 million. It was used only in the first quarter of 2025: 107,743 shares in January at $6.84, 555,294 in February at $6.71 and 71,602 in March at $6.51 — a total of 734,639 shares for $4.9 million. From April through December 2025 the company bought back nothing; $28.1 million of the authorization was still open at December 31, 2025. No further repurchase appears in the interim reports through July 29, 2026.

Dilution ran the other way at a brisk pace. In 2025 alone, 2.305 million options were exercised at an average of $4.98. The share count rose from 84,059,952 (December 31, 2024) to 86,056,804 (December 31, 2025) and on to 87,691,370 (June 30, 2026) — up 3.63 million shares, or 4.3 percent, in eighteen months, against $4.9 million of buybacks. At December 31, 2025 a further 1.916 million options were outstanding at an average exercise price of $7.87, and 7,593,824 shares were reserved for the compensation plans.

The parent company, Teekay Corporation Ltd., owns no ships and generates no operating cash flow. Its recurring income is dividends from Teekay Tankers plus interest on its own cash — the 20-F annual report for 2025 says so in as many words. At the regular quarterly dividend of $0.25 per share on 10.6 million shares held, that is roughly $2.7 million per quarter, or about $10.6 million a year. Its own special dividend of $1.00 per share cost $87.4 million in June 2026 — eight times as much.

The difference comes out of the cash pile, and it is melting: $183.4 million at December 31, 2024, $120.2 million at December 31, 2025, $127.4 million at March 31, 2026 — and, after the payout, only $56.4 million at June 30, 2026. That is $127.0 million less in eighteen months, a 69 percent decline. Another special dividend of the same size could no longer be funded from cash on hand alone. It would depend on Teekay Tankers declaring a special dividend again — which the subsidiary did in May of 2023, 2024, 2025 and 2026, most recently $1.00 per share, sending $13.3 million up to the parent. Anyone judging Teekay's ability to pay should therefore not look at consolidated earnings but at exactly two lines: the parent's cash and the subsidiary's dividend declaration.

Ategrity does not sell its own policies. Everything runs through licensed surplus lines brokers and wholesale agents — and that channel is tightening. The 10-K for 2025 states it directly: "The industry's three largest wholesale distribution corporations represented 46.5% of gross written premiums for the year ended December 31, 2025." The concentration disclosure in the notes puts a dollar figure on it: $270.4 million of direct written premiums through three distribution partners, each accounting for more than 10 percent of total revenues. A year earlier it was exactly one partner, at $105.3 million or 24.1 percent.

The dependency has therefore almost doubled within twelve months — precisely during the growth phase that carries the stock. This clears any materiality bar: 46.5 percent of gross written premiums is far beyond a concentration threshold, and the three houses — the filing does not name them — are wholesale groups with their own interests in commissions and capacity allocation. If one of them moves its book, Ategrity does not lose a customer — it loses a channel. The figure is updated annually in the 10-K, Item 1 "Distribution," and in the concentration note.

On February 12, 2026, eight months after the IPO, Ategrity's board authorized a share repurchase program of up to $50 million. Measured against market capitalization the number looks small; measured against the shares that actually trade it is large. On the cover page of its 10-K for 2025, the company puts the market value of shares held by non-affiliates at roughly $200.2 million (as of June 30, 2025). The authorization therefore equals about a quarter of the public float and 8.1 percent of stockholders' equity as of December 31, 2025 ($614.3 million).

Nothing has been drawn so far. The quarterly report (10-Q) as of March 31, 2026 puts it plainly: "As of March 31, 2026, no shares had been repurchased under the program, and $50.0 million remained available for future repurchases." The second-quarter earnings release of July 29, 2026 mentions no repurchases either. That leaves a standing buy order the size of a quarter of the float hanging over a thinly traded stock — and the first filing that would have to show any repurchases is the second-quarter 10-Q with its "Issuer Purchases of Equity Securities" disclosure.

Ategrity Specialty Insurance Company Holdings' investment portfolio contains a line you do not expect at a property and casualty insurer: "Loans to affiliates" — $106.5 million as of December 31, 2025, unchanged as of June 30, 2026, up from just $13.5 million a year earlier. Behind it are two loans to the group of majority owner Zimmer Financial Services Group (ZFSG), which holds 80.7 percent of the stock: a $94.0 million loan to Zimmer Insurance Services, LLC at a fixed 5.5 percent, maturing April 30, 2032, backed by a guarantee and pledge agreement with ZFSG, plus a $12.5 million promissory note at 7.42 percent maturing December 31, 2029. The larger loan was funded by a $97.2 million redemption from the affiliated utility partnership on March 31, 2025.

The scale matters: $106.5 million equals 16.0 percent of stockholders' equity of $664.4 million (June 30, 2026) and roughly 9 percent of total invested assets of $1,175.8 million. Interest income from the two loans together was $4.85 million in 2025 ($3.9 million of it from the ZIS loan) and $3.05 million in the first half of 2026, a visible slice of investment income. For shareholders it means that part of the money set aside to pay claims is a receivable from the majority owner running to 2032 rather than a tradable bond. The filings disclose no call right, and the loan is carried at unpaid principal balance — that is, without mark-to-market.

The founding family has contractually committed to vote for the deal: Series U and Series R of UM Partners, LLC, Dylan B. Lissette, Timothy P. Brown and the Rice Family Foundation lock up roughly 42 percent of Utz's common stock according to the press release; the Schedule 13D/A filed July 22, 2026 breaks out the individual positions (Series U alone holds 50,616,650 shares — 37.3 percent of the Class A on an as-exchanged basis, and a good 35 percent measured against all common stock). That makes the first hurdle — a majority of all outstanding common stock — look like a formality. The second one is not: the merger agreement additionally requires a majority of the votes cast by "disinterested stockholders" under Section 144 of the Delaware General Corporation Law — and those locked-up 42 percent are expressly excluded from that group.

Arithmetically, then, the decision sits with the roughly 83.3 million Class A shares outside the locked-up votes (88,613,213 less about 5.3 million locked-up Class A shares as of July 15, 2026; officers are excluded on top of that). Work backwards from $14.25 and "approximately 91 percent" and you get a July 20, 2026 closing price of about $7.46 — the entire premium hangs on that second hurdle. If it fails, either side can terminate; the company owes a $50 million termination fee in specified circumstances, and the outside date runs to April 20, 2027.

Alongside its result under U.S. accounting rules, Utz reports an "Adjusted EBITDA." In 2025 the gap between the two became large: a $7.7 million net loss turns into $216.5 million of adjusted earnings through the reconciliation in the annual report. The single biggest step is called "Business Transformation Initiatives" and came to $65.4 million — after $28.1 million the year before. The footnote spells out what sits inside: start-up costs, consulting, professional and legal fees for restructurings, severance for eliminated driver positions, sales of distribution rights along with the disposal of trucks, and the transition to a new enterprise planning system.

The point is not that these costs are made up — they are real money. The point is the repetition: a "transformation" that recurs in a second consecutive year and more than doubles while doing so is not a one-off, it is a cost category. It continued in the first quarter of 2026: $7.9 million of "Supply Chain Transformation" plus $5.9 million of "Corporate Transformation" in thirteen weeks, after $9.0 million plus $6.0 million in the prior-year quarter. Utz recut these categories in the first quarter of 2026 and now also books the former "acquisitions and divestitures" and "financing-related costs" items there — so the line is edging down, on a broader basis. Value Utz off the adjusted number and you are paying for a company that has not existed in that form for at least two years: unadjusted EBITDA fell from $183.1 million to $122.7 million in 2025, while the adjusted figure rose from $200.2 million to $216.5 million.

Ever since it went public through the Collier Creek SPAC shell, Utz Brands has had a Tax Receivable Agreement with its founding family — an arrangement under which the family is paid most of the group's future tax benefits in cash. On the balance sheet as of December 28, 2025 that obligation is carried at $24.0 million: $4.4 million in current and $19.6 million in non-current accrued expenses. The merger agreement of July 20, 2026 terminates the same contract — and according to the 8-K filed July 22, 2026, $44 million flows to the "Continuing Stockholders," meaning the family vehicles Series U and Series R of UM Partners, LLC. That is roughly $20 million more than the balance sheet had set aside for the obligation, and more than five times the reported fiscal 2025 result (a $7.7 million net loss). Fairness requires the other number from the same footnote: Utz put its projected total obligation under the contract at $56.2 million and deliberately left $32.2 million of that unbooked, because the related tax benefit is not probable enough under U.S. accounting rules. Against that projection, $44 million is a discount of a good $12 million — the $20 million premium holds only against the carried amount.

The payment comes from the acquired company itself, not from the buyer — and the joint press release names it explicitly as a financing component: part of the $44 million is reinvested by the family straight into its future 50 percent stake. For Class A holders that is not a headline, but it is a number: cash leaving the company's account for a party sitting on the other side of the table. How the independent special committee valued that amount has to be laid out in the going-private statement (Schedule 13E-3) and the proxy statement.

Global Self Storage has 36 employees — and no payroll department of its own. Note 10 of the 2025 annual report (related party transactions) explains that an outside professional employer organization handles the administration and that Midas Management Corporation, a subsidiary of Winmill & Co. Incorporated, "acts as a conduit payer of compensation and benefits" for employees who are in part concurrently employed by the company and its affiliates. The amount that flowed to Midas Management in 2025: $3,152,802 (2024: $3,039,878). That equals 24.8 percent of the $12,705,245 of annual revenue. Add $28,050 of administrative and support cost allocations to Winmill & Co. and $110,056 of employer retirement plan matching.

The connection is personal: Mark C. Winmill is chief executive officer, president and chairman of the board of Global Self Storage, and at the same time executive vice president and a director of Winmill & Co. as well as a trustee of the Winmill Family Trust, which owns all of that holding company's voting stock. As of April 9, 2026 affiliates, directors and employees together held roughly 12.2 percent of the shares; Winmill himself is listed with 973,079 shares, or 8.52 percent. All of it is fully disclosed and hardly unusual for a company that grew out of a fund manager — but it means the single largest cost block of this REIT runs through a company attributable to the same family.

Global Self Storage has paid $0.0725 per share per quarter for years, an annualized rate of $0.29. The May 8, 2026 earnings release explicitly describes the payout as "maintained and covered." The arithmetic behind that has grown thin: funds from operations (FFO) fell 12.6 percent in the first quarter of 2026 to $852,563, while the dividend actually paid cost $820,470. That is 96 percent of FFO — a year earlier, with FFO of $975,343 and $815,286 paid out, it was 84 percent.

The change of sign sits in the cash flow statement of the quarterly report: after $979,931 of cash provided by operating activities, $52,298 of improvements and equipment additions and $155,343 of principal payments, the dividend was no longer covered — the balance of cash, cash equivalents and restricted cash fell by $48,180 after rising $59,997 in the prior-year quarter. The 2025 annual report states the position bluntly itself: "Capital resources derived from retained cash flow have been and are currently expected to continue to be negligible."

On June 16, 2026 Global Self Storage stockholders approved the amended and restated equity incentive plan, and on June 29, 2026 the company registered 1,000,000 new shares for it with the U.S. securities regulator, the SEC (Form S-8). Against the 11,431,732 shares outstanding as of April 9, 2026 that is 8.8 percent — and the proxy statement arrives at the same order of magnitude: authorizing the additional million shares "would increase the Company's total potential dilution to approximately 8.8%." The prior overhang was 3.34 percent. After the vote, 1,393,661 shares in total are reserved for compensation purposes, or 12.2 percent of the capital.

The pushback is notable: the plan drew 3,717,027 votes in favor, but 1,298,704 against and 69,240 abstentions — roughly a quarter of the votes cast opposed it. The advisory vote on executive compensation split almost identically, 3,710,166 to 1,303,882. For a company with 11.4 million shares and 2025 FFO of $4.03 million, a million extra shares is not a footnote: the old 2017 plan was capped at 760,000 shares and would have expired on October 16, 2027 — the new one runs ten years from the stockholder vote. The "change in control" threshold was also lifted from 30 percent to more than 50 percent of the voting power.

In October 2025 Johnson & Johnson announced its intention to separate its orthopaedics business. The franchise sold $9,258 million in fiscal 2025 — 9.8 percent of group sales and 27.4 percent of the MedTech segment. In both the annual and the quarterly report the company names no fixed route, saying instead that it intends to explore multiple paths; completion is targeted within 18 to 24 months of the announcement.

It is the slowest-growing part of the group: up 1.1 percent in fiscal 2025, with spine, sports and other down 2.5 percent. In parallel, an orthopaedics restructuring programme has been running since 2023 with total costs now around $0.8 billion, substantially completed in fiscal 2025, plus a second programme for surgery launched in 2025 with expected costs of $0.9 to $1.0 billion. The side effect matters for investors: after a separation the MedTech time series will again not be comparable with prior years — just as after the Kenvue separation in 2023.

STELARA was the company's largest-selling medicine for years. In fiscal 2025 sales fell from $10,361 million to $6,078 million — down 41.3 percent, down $4,283 million in a single year. That equals 7.5 percent of Innovative Medicine segment sales in fiscal 2024 ($56,964 million) and 4.5 percent of group sales. Immunology as a therapeutic area shrank 11.8 percent to $15,728 million as a result.

The company writes in its annual report that it expects further biosimilar launches and consequently further declines in STELARA sales; U.S. sales were still roughly $3.8 billion in fiscal 2025. Two further cliffs are named: for OPSUMIT (together with OPSYNVI, $2,325 million of fiscal 2025 sales) the company expects generic competition in 2026, and for SIMPONI ($2,668 million) at least two parties are pursuing biosimilar approval in the United States. In fiscal 2025 the shortfall was fully offset: TREMFYA up $1,485 million to $5,155 million, DARZALEX up $2,681 million to $14,351 million.

At December 28, 2025 the balance sheet carries $48,772 million of goodwill and $50,403 million of intangible assets — together $99,175 million. That is 49.8 percent of the $199,210 million of total assets and 121.6 percent of the $81,544 million of shareholders' equity.

The jump came from acquisitions: $17,541 million in fiscal 2025 (Intra-Cellular Therapies for roughly $14.5 billion, closed April 2, 2025, adding $3,488 million of new goodwill) after $15,146 million in fiscal 2024. Intangible assets grew from $37,618 million to $50,403 million within a year as a result. Part of the funding came from $9.2 billion of new senior unsecured notes; net debt rose from $12.1 billion to $27.8 billion. The running charge sits in cost of products sold: $4,600 million of intangible amortization in fiscal 2025 after $4,500 million in 2024, or 4.9 percent of sales.

The sales discussion in the 2025 annual report contains a sentence that is rarely quoted: in fiscal 2025 Johnson & Johnson shipped through three wholesalers that together accounted for roughly 48.4 percent of total gross revenues — individually 21.8, 15.5 and 11.1 percent. In 2024 the split was almost identical at 20.5, 15.6 and 12.3 percent.

The offsetting entry sits on the balance sheet: accrued rebates, returns and promotions stood at $19,124 million at December 28, 2025, after $17,580 million a year earlier — more than a quarter's gross profit and 23.5 percent of shareholders' equity. The company also quantifies that revisions to prior-period estimates on its most significant U.S. rebate liabilities amounted to roughly 3.0 percent of U.S. Innovative Medicine revenue in fiscal 2025, and roughly 2.0 percent in fiscal 2024.

At June 28, 2026 Johnson & Johnson reported a present value of the talc reserve of $3.7 billion in Note 11 of its quarterly report, about 40 percent of it as a current liability. Five days after that filing, on July 27, 2026, the company announced a comprehensive resolution of the ovarian talc claims carrying a commitment of $5.5 billion — the first payment no more than $3 billion in 2027, nothing further before 2028.

The commitment equals 6.7 percent of the $81,544 million of shareholders' equity and 5.8 percent of annual sales; roughly $1.8 billion of it has not been booked. The item is no side note at this company: in 2023 it charged earnings by roughly $7.0 billion, in 2024 by $5.1 billion, and in 2025 a reversal of roughly $7.0 billion lifted them. The reserve ran from $11.6 billion of present value at the end of 2024 through $3.4 billion at the end of 2025 to $3.7 billion. The commitment is also conditioned on participation of at least 95 percent of the remaining claims; the number of U.S. plaintiffs rose from 74,360 (December 28, 2025) to roughly 76,000 (June 28, 2026).

On June 25, 2026 SEALSQ announced that Quantisimo Corp — a special purpose vehicle jointly established with parent company WISeKey — had signed a non-binding letter of intent with listed shell company GigCapital8 Corp. On completion the combined company is expected to carry a pre-money enterprise value of roughly $575 million; the parties also intend to acquire up to five further quantum companies.

The order of magnitude is the real finding here: $575 million exceeds the entire market capitalization of SEALSQ itself, which stood at roughly $521 million as of July 28, 2026 (222,773,999 shares × $2.34). The platform that does not yet exist is supposed to be worth more than the listed parent of the idea.

According to the announcement, selected holdings, technologies and intellectual property of SEALSQ are to be contributed to the vehicle — precisely the assets on which SEALSQ has recently spent more than $60 million from its own investment pot. Nothing is binding so far: definitive agreements, due diligence, regulatory and shareholder approvals and financing are all outstanding. Closing is expected no earlier than the first quarter of 2027.

On September 3, 2025 the board of SEALSQ adopted an investment policy permitting up to $30 million of company funds or proceeds from future issuances to be invested in Bitcoin, Ethereum, HBAR and WECAN tokens. Measured against cash of $417.7 million as of December 31, 2025 that is a good 7 percent; measured against equity of $461.5 million, roughly 6.5 percent; and measured against a market capitalization of roughly $521 million (data as of July 28, 2026), just under 6 percent.

The last item is the notable one: WECAN tokens are issued by WeCan Group SA — the Swiss company in which SEALSQ itself held 31.9 percent as of December 31, 2025 and of which it took majority control in June 2026. At the balance sheet date the actual holdings were still immaterial according to the report; the custody account was still being set up.

As of December 31, 2025 the books of SEALSQ carried a current receivable of $8,656,171 from parent company WISeKey International Holding AG and its affiliates, for management fees and advances. That is close to half of the entire year’s revenue of $18.3 million. In the other direction, SEALSQ owed the parent $2,180,054 at the same date.

What makes the number interesting is a second finding in the same report: WISeKey disclosed an accumulated deficit of approximately $299 million as of June 30, 2025, and SEALSQ lists this explicitly as a risk factor of its own. On top of that, SEALSQ booked $2.5 million of other operating income in 2025 from services rendered to the WISeKey group — after $0.2 million the year before.

Among the liabilities of Editas sit $44.5 million of long-term deferred revenue as of March 31, 2026 — money already received but not yet recognizable as revenue. The quarterly report (10-Q) attributes $40.5 million of that to the collaboration with Bristol Myers Squibb through its subsidiary Juno Therapeutics. In the first quarter of 2026, as in the prior-year quarter, not a single dollar of it was recognized.

The reason lies in the contract design: Editas recognizes the amount only when the associated option rights are exercised, lapse or expire. The collaboration was extended in 2024 through November 2026; one extension option had already expired as of March 31, 2026, and BMS retains the right to one further year. A single contractual decision therefore governs a revenue item as large as the entire 2025 fiscal year ($40.5 million) — without a cent of additional cash.

In October 2024 Editas sold DRI Healthcare up to 100 percent of the future fixed and sales-based annual license fees from the Vertex license agreement — amounts between $5.0 million and $40.0 million a year, running through 2034 — for a single payment of $57.0 million. Under U.S. accounting rules that is not a sale: the quarterly report (10-Q) for the period ended March 31, 2026 carries the amount as debt, at an estimated 7.7 percent effective interest rate.

The consequence is visible on the balance sheet: $54.7 million of "liability for sale of future revenues" as of March 31, 2026, down from $58.6 million at December 31, 2025. In the first quarter of 2026 alone $5.0 million flowed to DRI, plus $1.0 million of non-cash interest expense. Anyone modeling the earning power of Editas should not read the Vertex fees as cash: they still run through the top line — the annual report (10-K) for 2025 books $10.0 million of annual license fee — but the money itself repays the DRI liability.

In the May 26, 2026 offering every buyer received a warrant alongside every share — 55,555,556 of them, at an exercise price of $3.50. The unusual part is not the warrant but its expiry. According to the Form 8-K filed the same day, it ends on the earlier of two dates: three years after issuance, or 30 days after the company first publicly announces Phase 1 data for EDIT-401 disclosing at least three patients who each showed a greater than 80 percent reduction in LDL cholesterol with at least one month of follow-up.

That inverts the usual logic: the good news starts the clock. Holders who fail to exercise within 30 days lose the right. For Editas, success would mean up to $192.5 million of additional capital — and for every existing shareholder another 55.6 million shares on top of the 153,461,838 outstanding after May 27, 2026, roughly a third more. Anyone watching this stock should read the first Phase 1 release as a balance-sheet event, not just a medical one.

The release of May 14, 2026 was read as a commercial breakthrough: a supply agreement with Lumilens Inc., an initial order of $50 million, potentially more than $500 million cumulatively over five years. The same text states the price of that relationship, and it is rarely quoted along with it: POET granted Lumilens a warrant on up to 22,921,408 of its own common shares at $8.25 with a nine-year term. Immediately exercisable: 2,292,140 shares; the remainder vests in tranches keyed to cumulative payments by Lumilens of up to $500 million.

Measured against the 172,590,000 shares outstanding on June 26, 2026, that is 13.3 percent — dilution potential that never appears in the order figure. Where it does not appear is equally notable: the prospectus supplement of May 18, 2026, four days after the release, lists outstanding warrants at 37,364,941 shares with a weighted-average exercise price of $4.39 — exactly the March 31, 2026 position from note 12 of the interim statements. So the Lumilens warrant is not in there. Read the fully diluted share count off the prospectus and you arrive at 238.1 million instead of up to 261.0 million.

On April 14, 2026 POET disclosed that it expects to be treated as a Passive Foreign Investment Company (PFIC) for fiscal 2025. This U.S. tax classification applies to a foreign corporation when at least 75 percent of its gross income is passive — interest, dividends, rents — or at least 50 percent of its assets produce such income. At POET both tests are easy to follow: 2025 brought $4,553,061 of other income including interest against $1,074,865 of revenue, and 96 percent of total assets as of December 31, 2025 sat in current assets, essentially cash and guaranteed investment certificates.

The finding is not an accounting failure but an independent, formula-driven diagnosis: under U.S. tax law this business was economically closer to a pot of money with a development department attached than to a manufacturer in 2025. The board has therefore resolved to redomicile the company in the United States, which would settle the PFIC question going forward. The June 30, 2026 report on the annual meeting, however, lists only the election of directors and the appointment of auditors as approved items — so the redomiciliation itself remains open.

On April 25, 2023 POET announced its first purchase orders for production units of its optical engines — for a company that had been developing since 2013, proof that a customer was paying. The customer was Celestial AI. On April 23, 2026, almost exactly three years later, Marvell Semiconductor Inc. — which had acquired Celestial AI — cancelled every order in writing. The stated reason appears verbatim in the SEC report of April 27, 2026: Marvell indicated that POET "had made disclosures of information related to the Purchase Order and shipping information in contravention of its confidentiality obligations."

That is the remarkable part. Not price, not quality, not a technology switch ended the relationship, but the way POET talked about the order — at a company whose share price fed on exactly such announcements for years. The same report points to an order "with another technology company with a value of approximately $5 million" — but describes it as recently disclosed, so it is not a replacement for what was cancelled; three weeks later the Lumilens order of $50 million followed. Whether either becomes booked revenue is decided in the quarterly figures — most recently $503,389 in the first quarter of 2026.

A company with $1,074,865 of annual revenue writing loans in the tens of millions — that is what note 22 of the interim statements as of March 31, 2026 discloses, and it is no footnote curiosity. On January 7, 2026 POET advanced $10 million and on January 21, 2026 another $5 million to an entity the filings identify only as "the Borrower". Note 23(a) adds a further $15 million advanced on April 23, 2026 on the same terms. That is $30 million in total — 28 times annual revenue and roughly 6.7 percent of shareholders' equity as of March 31, 2026.

The terms read oddly for a pure treasury transaction: 6.0 percent interest per year, compounded daily, rising to 8.0 percent on default. Repayment falls due after five years — or earlier upon a "Liquidity Event", meaning a merger, reorganization or acquisition of the borrower. And the decisive clause: upon certain events POET may convert the loan and accrued interest into equity securities of the borrower. That is the architecture of a venture investment, not of a loan. Who the borrower is, why a pre-revenue chip developer is funding it, and what POET would receive on conversion appears in none of the filings reviewed.

As of December 31, 2025, $12,518 million of asset retirement and remediation obligations sat on the balance sheet, up from $12,032 million a year earlier; $11.3 billion of that is long term. For 2026 and 2027 ExxonMobil expects payments of $1.3 billion and $1.5 billion. Revisions during 2025 alone increased the provision by $1,154 million.

The more interesting part sits alongside: for the manufacturing sites the obligation only becomes firm once a shutdown is decided. Because those locations are planned to operate indefinitely, the company states the timing cannot be estimated — and therefore the fair value of the obligation cannot be measured. Those obligations are not included in the $12.5 billion. For context: the reported amount already equals 43 percent of 2025 net income.

At the annual meeting on May 27, 2026, 2,216,403,048 shares (71.2 percent) voted for the redomiciliation to Texas and 896,852,562 shares (28.8 percent) against. For comparison: ratification of the auditors drew 96.4 percent and the say-on-pay vote 92.9 percent. The move became effective on July 1, 2026; ExxonMobil Holdings Corporation (Texas) has been the successor registrant since, with a one-for-one exchange.

Economically nothing changes; legally something does. Under Texas law a derivative proceeding requires a formal written demand first. Inspecting books and records requires 5 percent ownership or six months as a record holder, and a publicly traded Texas corporation may deny inspection demands from shareholders with whom it is in litigation. The board expressly declined to introduce an ownership threshold for derivative proceedings or to raise the bar for shareholder proposals beyond Exchange Act Rule 14a-8.

As of December 31, 2025, ExxonMobil reported 19,311 million oil-equivalent barrels of proved reserves. The change from 2024 includes, alongside 1.8 billion barrels of production and 0.1 billion of asset sales, 0.9 billion barrels of downward revisions, mainly in the United States. Against that stood 2.1 billion barrels from extensions and discoveries and 0.1 billion from acquisitions. Net, the company replaced roughly 72 percent of the year's production; without the revisions it would have been 122 percent.

In parallel, the SEC-mandated standardized measure of discounted future net cash flows fell from $185,664 million to $154,266 million — a 16.9 percent decline arising almost entirely from the lower average price of the year. ExxonMobil expressly considers the measure an unreliable estimate of the value of its reserves. That is exactly why the trend matters more than the absolute figure.

ExxonMobil repurchased its own shares for a combined $57,650 million between 2023 and 2025 ($17,748m, $19,629m and $20,273m). Even so, the weighted average share count of 4,305 million in 2025 stood 6.2 percent above the 2023 figure of 4,052 million.

The cause appears as a non-cash transaction below the cash flow statement: for Pioneer Natural Resources the company issued 545 million of its own shares with a fair value of $63 billion on May 3, 2024 and assumed $5 billion of debt. It acquired identifiable assets of $88 billion with goodwill of only $1 billion. As of March 31, 2026, 4,145 million shares were outstanding, down from 4,179 million at the end of 2025 — the buybacks are catching up with the dilution, but for two years they merely neutralised an acquisition.

Of $11,563 million of income taxes paid in cash in 2025, Note 15 of the annual report shows $5,000 million going to the United Arab Emirates and only $1,114 million to the United States ($944 million federal, $170 million state). Canada received $1,207 million, Guyana $1,100 million, and all other countries together $3,142 million.

The tax rate reconciliation shows the effect on its own line: the Emirates rate differential raised the group effective tax rate in 2025 by $3,405 million, or 8 percentage points. The reported rate was 28 percent under U.S. accounting rules and 31 percent including equity company taxes. Anyone tying this company's tax burden to U.S. policy is measuring the smaller half: of 2025 pre-tax income, $11,000 million arose in the United States and $30,268 million abroad.

Operating activities provided ExxonMobil with $51,970 million in 2025 and $28,358 million went into property, plant and equipment. That left $23,612 million. Distributions totalled $37,504 million — $17,231 million of dividends and $20,273 million of buybacks. The $13,892 million gap is no outlier: it was already $5,617 million in 2024, and in 2023 distributions were only barely covered.

The bill is paid from the balance sheet. Cash fell from $23,187 million to $10,681 million during 2025, and net debt to capital rose from 4.5 percent (2023) through 6.5 (2024) to 11.0 percent. The first quarter of 2026 continued the pattern: $8,705 million provided, $6,470 million invested, $9,202 million distributed, funded partly with $9,075 million of newly issued commercial paper; cash fell further to $8,435 million. Another $20 billion of buybacks is announced for 2026.

Personnel expense jumped from $1,749 million to $2,458 million in the third quarter of fiscal 2026, up 40.5 percent. The income statement does not show the cause; the earnings release does: $563 million of severance costs, disclosed as a special item. That equals 10.0 percent of the quarter's $5,628 million of net income.

What stands out is the timing. In the same quarter net revenue grew 14 percent and processed transactions 10 percent. A company growing at double digits was cutting staff on that scale. Fiscal 2025 already carried severance costs to realign the organizational structure; the workforce had grown from roughly 31,600 to roughly 34,100 beforehand.

Visa guarantees settlement of payments between the participating banks. The exposure is the sum of unsettled transactions at any point in time. In fiscal 2025 the maximum daily settlement exposure was $153.4 billion and the average $91.2 billion. Against that, total collateral as of September 30, 2025 stood at $8.8 billion (September 30, 2024: $7.7 billion).

The peak exposure equals 3.8 times annual net revenue and 4.4 times equity as of June 30, 2026. As of September 30, 2025 Visa also held $9.2 billion of its available liquidity explicitly for the event that one or more institutions cannot settle. The risk is managed, but its sheer size bears no relation to the balance sheet.

Visa's reported net revenue only emerges after client incentives to banks, merchants and partners are deducted. That line grew faster than the business: fiscal 2022 $10,295 million of $39,605 million of gross revenues (26.0 percent), fiscal 2023 $12,297 million of $44,950 million (27.4 percent), fiscal 2024 $13,764 million of $49,690 million (27.7 percent), fiscal 2025 $15,751 million of $55,751 million (28.3 percent). Over the first nine months of fiscal 2026 the share was 28.1 percent.

One percentage point equals roughly $558 million on a fiscal 2025 basis. Had incentives stayed at the 2022 level, Visa would have reported around $1.3 billion more net revenue in fiscal 2025. Visa names no target, pointing instead to negotiations and contract execution. Incentive obligations on the balance sheet rose from $10,369 million (September 30, 2025) to $11,429 million (June 30, 2026).

The U.S. litigation escrow account funds settlements and judgments in the U.S. interchange cases. As of September 30, 2025 it held $2,990 million. Over the nine months to June 30, 2026 Visa deposited $875 million — and paid out $2,977 million to merchants who had opted out of the class settlement or belonged to the injunctive relief class. The remaining balance was $888 million.

That equals 7.4 percent of fiscal 2025 net revenue flowing out within three quarters. The accrual for U.S. covered litigation fell in parallel from $3,033 million to $1,274 million. The buffer is therefore largely used up, while more than 100 merchant claims remain open in Europe and fresh suits were filed in April, May and June 2026.

In an exchange offer completed in May 2026, Visa accepted 3 million class B-1 and 120 million class B-2 shares and issued 61 million class B-3 and 23 million class C shares in return. The tendered shares were retired. The decisive sentence comes next: future downward conversion rate adjustments hit class B-3 with four times the impact of class B-1 and twice that of class B-2.

Economically, part of the banking group has bought its way out of liability for the interchange cases. The buffer protecting class A remains, but it rests on fewer shoulders: as of June 30, 2026, 95 million as-converted class B shares carried the load that on September 30, 2025 was spread across 191 million. In total, all classes as converted came to 1,880 million class A equivalents against 1,702 million reported class A shares — 178 million, or 10.5 percent, of latent dilution.

At the annual meeting on May 13, 2026 shareholders approved an increase of the 2023 equity incentive plan by 65 million shares. The plan may now issue a total of 153 million shares — 9.4 percent of the 1,630,600,639 shares outstanding as of April 29, 2026. The vote was 971,044,532 in favor and 28,539,051 against.

Six weeks later, on June 26, 2026, the board approved compensation for the executive team. Chair and Chief Executive Officer Lisa Su receives a base salary of $1,375,000 effective July 1, 2026 and equity awards with a target value of $36 million on August 15, 2026, 75 percent of it performance-based.

The yardstick is the interesting part. The performance awards pay out at 0 to 200 percent of target based on total shareholder return relative to the companies in the S&P 500 over three years. On top comes an additional 0, 25 or 50 percent depending on how non-GAAP earnings per share for fiscal 2028 compare with the target for non-GAAP earnings per share for fiscal 2026. Non-GAAP means: excluding amortization of acquisition-related intangibles and excluding stock-based compensation. Precisely the two items that together came to $3,892 million in 2025.

AMD discloses goodwill by reporting unit. Of the $25,126 million on the balance sheet as of December 27, 2025, $21,072 million sits in Embedded — 83.9 percent. Data Center carries $3,690 million and Client and Gaming $364 million.

Embedded is essentially the Xilinx business acquired in 2022. And it is the only segment that shrank: revenue fell from $5,321 million (2023) through $3,557 million to $3,454 million (2025), and segment operating income from $2,628 million to $1,243 million — down 52.7 percent in two years. In the first quarter of 2026 it grew again for the first time, up 6 percent to $873 million.

The impairment test took place in the fourth quarter of 2025 and was purely qualitative: AMD concluded it was not more likely than not that the carrying value of any reporting unit exceeded its fair value. There was no write-down. For scale: the $21,072 million equals 33.4 percent of stockholders' equity of $62,999 million.

The annual report (10-K) puts unconditional commitments at roughly $12.2 billion as of December 27, 2025, of which $8.5 billion fell in fiscal 2026. Three months later, as of March 28, 2026, the quarterly report (10-Q) shows roughly $25.7 billion — with $18.3 billion for the remainder of fiscal 2026. That is a 110 percent increase in one quarter.

According to the report, the commitments relate mainly to wafers, substrates and components from third parties as well as multi-year cloud service provider arrangements. In parallel, leases not yet commenced rose from $1.3 billion to $4.4 billion.

The scale is worth a second look: $25.7 billion equals 74 percent of fiscal 2025 revenue of $34,639 million and 2.1 times cash, cash equivalents and short-term investments of $12,347 million as of March 28, 2026. Orders of that size are the flip side of an order book — they are a bet that demand holds. AMD names the risk in its own report: overestimating customer demand leads to excess inventory and higher production costs, "particularly since we have prepayment arrangements with certain suppliers."

The quarterly report (10-Q) for the quarter ended March 28, 2026 carries an item under Note 8 that did not appear in this form in the fiscal 2025 annual report: lease guarantees. AMD backs data center lease obligations of commercial partners with terms of up to 15 years. The report puts the maximum gross exposure at $4.1 billion.

For scale: that equals 6.4 percent of the $64,462 million of stockholders' equity and 1.3 times total debt of $3,224 million at the same date. The guarantees become payable if a partner fails to pay its rent.

One clause in the note ties this item to the other big theme of this analysis: guarantees "may be issued in exchange for warrants." AMD records them as a credit derivative within other long-term liabilities; changes in fair value have run through other income and were, by the company's own account, not material. The amount is.

In October 2025 AMD granted OpenAI a warrant for up to 160 million shares at an exercise price of $0.01; in February 2026 a warrant of the same size followed for Meta Platforms. Together that is 320 million shares — 19.6 percent of the 1,630,600,639 shares the cover page of the quarterly report (10-Q) lists as of April 29, 2026. Full exercise would bring AMD $3.2 million.

The tranches vest when the two customers hit certain purchase milestones for AMD Instinct GPUs and the AMD share price clears certain targets; the OpenAI warrant adds a stock-performance threshold. They are exercisable through October 5, 2030 (OpenAI) and February 23, 2031 (Meta).

As of March 28, 2026 no tranche had vested, so the rights appear nowhere in the financial statements — not even in the diluted share count of 1,650 million. That changes the moment the first tranche vests: AMD will account for the warrants as a liability until the conditions for equity classification are met. Anyone projecting earnings per share today is working with a denominator that can grow by up to a fifth.

Next to the net loss, the cash flow statement in the annual report on Form 10-K for 2025 carries a second large outflow: "distributions to affiliates". Note 13 puts it at $3,552,696 for 2025 and $5,780,578 for 2024, in both cases to affiliated Fonon Corporation. The report attributes the larger part to payroll costs and allocated shared facility and overhead costs ($2,917,843 in 2025, $5,780,578 in 2024).

Scale is the point here. Over two years roughly $9.3 million moved to an entity within the same controlling shareholder's orbit — against annual revenue of $3.4 million (2024) and $8.3 million (2025). The 2024 distribution alone exceeded that year's revenue by two thirds. Over the same period the operating business burned $9.1 million (2024) and $6.4 million (2025), and the gap was closed with a steady stream of new shares. Anyone wondering where the money raised actually goes will find a substantial part of the answer in this line.

One sentence in the notes to the quarterly report on Form 10-Q as of March 31, 2026 sums up the entire financing machine at Laser Photonics. Between June 1, 2026 and the filing date, 5,613,586 shares were acquired under Series A-1 and A-2 warrants. Of those, only about 274,726 warrants were exercised for cash — proceeds: roughly $296,704. The remaining 6,550,778 warrants were exercised cashless and produced 5,338,860 new shares. The report states plainly: "No cash proceeds were received from the cashless exercises."

In eleven days that added more than 5.3 million shares without a single dollar entering the company — over 16 percent on top of the 32,597,325 shares outstanding on March 31, 2026. As of the same date, 17,511,441 warrants were still outstanding. The next round arrived on July 16, 2026: 2,528,572 warrants were exercised for cash at $0.975 (gross proceeds $2,465,357.70), and in return the company issued new Series A-7 warrants for 800,000 shares and Series A-8 warrants for 4,257,144 shares — plus 177,000 warrants for the placement agent.

On March 31, 2025, ICT Investments, the shareholder that controls Laser Photonics, bought the Beamer laser marking line from ARCH Cutting Tools for $255,824 in cash. The assets then moved on to Fonon Quantum Technologies, Inc. (FQTI), a sister company under the same control. On August 5, 2025, Laser Photonics bought those same assets from FQTI and paid with 3,000,000 of its own shares worth $8,434,322 ($2.80 per share at that day's close). The annual report on Form 10-K for 2025 names the result: a deemed dividend of $8,835,228; the income statement carries the line "Deemed dividend on common control acquisitions" at $8,789,754.

For scale: total revenue for 2025 was $8,342,008. The deemed dividend from this single transaction exceeds a full year of sales. And it was not the first one: on May 21, 2024, 3,000,000 shares worth $6,615,000 already went to affiliated Fonon Corporation in exchange for licenses. The contrast with an arm's-length deal is stark: for the operating subsidiary Control Micro Systems, Laser Photonics paid an unrelated seller $950,000 in cash plus 100,000 shares in October 2024 — and booked a bargain purchase gain of $3,857,999 on it.

The finding is fully disclosed and properly accounted for (ASC 805-50, transactions between entities under common control). What matters for investors is the direction: buying from strangers produced a bargain, buying from the controlling family produced a deemed dividend the size of a year of revenue.

The largest single item on Zepp's balance sheet is not a watch factory but a shareholding: 30 percent of Shenzhen-listed Jiangsu Yitong High-Tech, bought in February 2021 for $144.89 million in cash and carried at $135.0 million as of December 31, 2025. That is more than the entire company is worth on the exchange (roughly $68 million, using 14.68 million ADS equivalents at the $4.61 price documented in an insider filing for June 26, 2026).

The note on bank borrowings contains a sentence that is easy to skim past: at December 31, 2025 a bank loan of $33 million was outstanding that had been provided solely for this investment — and the group had pledged a 15.79 percent equity interest in Jiangsu Yitong to the bank, slightly more than half of its own stake. The share price of a Chinese listed company therefore helps determine how secure part of Zepp's balance sheet is. The repayment schedule calls for $55.7 million of bank borrowings to be repaid in 2026.

Zepp Health has two share classes: Class A with one vote and Class B with ten votes per share. Class B converts one-for-one into Class A at any time — and automatically on any transfer. The annual report (Form 20-F) for 2025 shows the balance of both classes on the balance sheet: 117,208,247 Class B shares at December 31, 2024, but only 99,277,687 at December 31, 2025. Over the course of one year, 17,930,560 super-voting shares disappeared — converted into Class A, equal to 7.6 percent of all 234.9 million shares outstanding.

The cross-check in the same report's ownership table is striking: the second-largest holder, Xiaomi-affiliated People Better Limited, is listed with 17,930,560 Class A and 17,930,552 Class B shares — the Class A position matches the drop in the Class B count share for share. The filing states both numbers but does not connect them and names no converting holder. What matters for investors is the mechanism: Class B shares cannot be traded through the ADS program, converted Class A shares can. Giving up half of a ten-vote stake trades control for sellability.

The annual general meeting of June 18, 2026 approved a maximum aggregate amount of variable compensation of $17,500,000 for the executive committee for the current financial year 2026 — plus $3,606,907 of fixed compensation for 2027 and $1,942,600 for the board of directors. For context: group revenue in fiscal 2025 was $77.3 million and equity as of March 31, 2026 had fallen to $45.7 million. And the ceiling is not an empty number: the company's own chart in the meeting invitation puts variable compensation actually granted for 2025 at $15.16 million — 95 percent of the $15.95 million ceiling approved at the time; in 2024 it was only 48 percent ($6.92 million of $14.50 million).

What stands out is not only the size but the vote: while the routine items — annual accounts, discharge, auditor — all drew more than 99 percent approval, this one came in at 66.02 percent in favor, with 11.07 percent against and 22.91 percent abstentions. The other compensation items lagged as well: 84.49 percent for the board of directors, 89.12 percent for fixed executive compensation. Almost a quarter of the shares represented declined to take a side. That is a governance signal you find in the wording of the resolution and in no financial metric.

In the amendment to the Perceptive credit agreement dated January 23, 2026, SOPHiA GENETICS secured two additional loan commitments of $12.5 million each. The second one — tranche D — hangs on a hard, checkable number: it may only be drawn once trailing twelve-month revenue exceeds $85.0 million. As of March 31, 2026 that figure stood at $81.2 million (fiscal 2025 at $77.3 million, less the first quarter of 2025 at $17.8 million, plus the first quarter of 2026 at $21.7 million). Roughly $3.8 million is missing.

Arithmetically the decision arrives with the half-year report: the second quarter of 2025 delivered $18.3 million in revenue. If the second quarter of 2026 beats that by more than $3.8 million — that is, comes in above roughly $22.1 million — the threshold is cleared. Reaffirmed full-year guidance of $92 million to $94 million implies an average of $23.4 million to $24.1 million for the remaining three quarters of 2026. For investors this is a rare case: a financing option whose trigger can be calculated from two published numbers. The price is more dilution — each drawn tranche makes a warrant for another 100,000 shares exercisable for the lender.

To settle opioid-related claims with all 50 states, the District of Columbia, Puerto Rico, three U.S. territories and the vast majority of eligible political subdivisions and federally recognized tribes, Walmart accrued roughly $3.3 billion in fiscal 2023. The fiscal 2026 annual report (10-K) records that as of January 31, 2025 the entire accrued liability had been paid.

That does not close the matter. For the cases not covered by the settlement — claims from healthcare providers, third-party payers and individuals — the company has explicitly not accrued a liability and states it cannot reasonably estimate any loss or range of loss. In the Florida Health Sciences Center case a jury trial began on September 18, 2025 and ended on December 8, 2025, when the court declared a mistrial. The retrial is scheduled to begin on August 27, 2026.

In parallel, the U.S. Department of Justice is pursuing a civil complaint over the dispensing of controlled substances; part of the claim was dismissed in 2024 and the remainder is set for trial in November 2027. For scale: the settlement already paid was equal to roughly eleven percent of one year of operating income.

In the quarter ended April 30, 2026 Walmart earned $5,330 million, up 18.8 percent from the same quarter a year earlier. Over the same period, total Walmart shareholders' equity fell from $99,617 million to $94,330 million — a decline of $5,287 million, or 5.3 percent.

The statement of shareholders' equity in the quarterly report (10-Q) explains the contradiction. Walmart declares the full annual dividend in one go: $7,896 million ($0.99 per share) was charged against retained earnings entirely in the first quarter, even though it is paid out in four instalments across the year. Add $2,096 million of share repurchases and $835 million of negative other comprehensive income.

The cash side belongs in the picture too. Operating cash flow for the quarter was $4.7 billion according to the earnings release, and free cash flow was negative $1.9 billion — a $2.4 billion swing from a year earlier. The first quarter is seasonally Walmart's weakest; but anyone reading shareholders' equity as a measure of substance should know that an accounting convention, not the business, drives this particular number.

During fiscal 2026 Walmart's Indian subsidiary PhonePe modified certain share-based payment arrangements — according to the annual report (10-K), "in contemplation of a potential initial public offering". That modification alone produced a non-cash charge of $0.7 billion, recorded in operating expenses within the Walmart International segment. It carried no tax benefit, which lifted the effective tax rate from 23.4 percent to 24.4 percent.

The remainder is more interesting. As of January 31, 2026 the report discloses roughly $3 billion of unrecognized compensation cost under subsidiary plans that contain performance or other conditions — explicitly including vesting upon an initial public offering. If those conditions are met, the cost lands in the applicable reporting period. For scale: total operating income in fiscal 2026 was $29,825 million.

The modification also diluted Walmart's own stake. After the freed options vested and were exercised, ownership of PhonePe fell from roughly 84 percent (January 31, 2025) to roughly 73 percent (January 31, 2026). Anyone valuing the Indian assets inside the group is now valuing a smaller slice than a year ago.

The segment table in the fiscal 2026 annual report (10-K) can be checked in a single line. Sam's Club U.S. booked $93,015 million of net sales and turned that into gross profit of $10,556 million. Segment operating expenses were $10,639 million. So merchandise contributed minus $83 million.

The reported segment operating income of $2,442 million therefore comes entirely from membership and other income of $2,525 million — arithmetically 103.4 percent of operating income. Two years earlier the picture was different: in fiscal 2024 merchandise still contributed a positive $141 million, in fiscal 2025 a positive $81 million. That change of sign disappears behind the headline "segment operating income up slightly".

In the first quarter of fiscal 2027 (quarter ended April 30, 2026) the arithmetic is sharper still: gross profit of $2,674 million, operating expenses of $2,674 million as well. Segment operating income of $674 million matches membership and other income for the same quarter to the dollar. The club dues carry the store.

The three-year summary in the 2025 annual report (10-K) contains a series that rarely makes it into the record-profit headlines. Net charge-offs — loans actually written off, not merely provisioned against — rose from $6,209 million (2023) to $8,638 million (2024) to $9,849 million (2025). That is up 59 percent in two years, while net income over the same span grew 15 percent.

The rate moves with it: 0.52 percent of the loan book (2023), 0.68 percent (2024), 0.74 percent (2025). Nonperforming assets climbed from $7,597 million to $10,359 million. In Card Services the net charge-off rate was 3.31 percent in 2025, 3.47 percent in the quarter ended March 31, 2026 and 3.34 percent in the quarter ended June 30, 2026; the bank's own 2026 outlook calls for approximately 3.4 percent.

Context in both directions: these are historically low levels, and with an allowance of $31.2 billion as of December 31, 2025 covering 1.83 percent of the loan book, the bank is well provisioned. But the direction is unmistakable, it has held for three years, and in a record year it goes unnoticed. That is precisely why it is here.

On June 25, 2026, as part of its succession planning, JPMorgan Chase announced that Doug Petno and Troy Rohrbaugh had been elected Co-Presidents of the firm and that Marianne Lake, until then CEO of Consumer & Community Banking, would retire after more than 25 years. For four members of the Operating Committee the compensation committee approved one-time retention awards in stock: $30 million each for Petno and Rohrbaugh, $20 million each for Mary Erdoes and Jennifer Piepszak — $100 million in total.

More interesting than the sum is the condition. The awards cliff-vest only after three years, and only if the firm achieves a three-year average return on tangible common equity of 12 percent across calendar years 2026, 2027 and 2028.

That bar sits strikingly low. In the quarter ended June 30, 2026, JPMorgan delivered 29 percent, or 23 percent excluding significant items; for full-year 2025 it was 20 percent, and 22 percent in 2024. The board is therefore setting the hurdle at roughly half of the level most recently achieved. That is either a deliberately conservative floor — or the committee's own view of how far earning power could fall by 2028 without the award lapsing.

On December 30, 2025, JPMorgan Chase entered into a forward purchase commitment for the Apple Card credit card portfolio; on January 7, 2026 it announced that Chase would become the new issuer. Closing is expected, per the 2025 annual report (10-K), "in approximately 24 months" — so around the end of 2027.

The accounting hits today regardless. The 2025 provision for credit losses of $14,212 million includes a $2.2 billion addition for lending-related commitments arising from precisely this transaction — for loans, in other words, that have no corresponding asset anywhere else on the balance sheet. That is roughly 15 percent of the full-year provision and about half of the $4.4 billion net addition to the allowance.

Capital pays too: the annual report discloses that the Standardized CET1 ratio as of December 31, 2025 was approximately 25 basis points lower because of the Apple Card transaction. For anyone reading the earnings series that means the 2025 provision is not directly comparable with prior years — a sixth of it belongs to a business that does not start until 2027.

A sentence in the other-assets note of the quarterly report (10-Q) for the period ended March 31, 2026 is easy to skip. The bank held 18.6 million Visa Class B-2 common shares, and those were "held at their nominal carryover basis" — effectively no carrying value at all. The reason: the shares carry transfer restrictions, and their conversion rate into freely tradable Visa Class A shares depends on the outcome of long-running litigation. It stood at 1.5075 as of March 31, 2026.

On April 13, 2026, Visa launched an exchange offer. JPMorgan tendered all 18.6 million shares, and the report flagged that a gain "may be recorded as early as the second quarter of 2026." Visa accepted on May 11, 2026. The July 14, 2026 earnings release carries the result: a $4.6 billion net gain — roughly 8 percent of the entire 2025 group profit.

The story does not end there. For each B-2 share tendered the bank received half a newly issued Visa Class B-3 share, which continues to be carried at its nominal value and remains subject to transfer restrictions. Visa is expressly authorized to extend further exchange offers. JPMorgan also holds derivatives referencing 11.6 million Visa B-2 shares from sales made before 2024, under which it retained the conversion-rate risk. An earlier Visa exchange had already produced a $7.9 billion gain in 2024.

Note 1 of the Form 10-Q for the quarter ended June 30, 2026 contains a table that is rarely quoted. Accrued warranty stood at $8,963 million at the balance sheet date, against $7,512 million a year earlier and $8,607 million at the end of 2025. For comparison: total operating income for fiscal 2025 was $4,355 million. The reserve is more than twice as large.

The movement matters more than the balance. In the quarter ended June 30, 2026 Tesla recorded a $615 million provision and used $504 million. On top of that it increased the liability for pre-existing warranties by $380 million — against $105 million in the prior-year quarter. In plain terms, a revision like that means vehicles and storage products already sold are costing more in warranty work than originally estimated.

The earnings release of July 22, 2026 names a concrete reason and assigns it to the energy business: higher warranty-related charges "due to vendor cell issue." Gross margin in the energy segment fell from 30.3 percent to 20.4 percent in the same quarter.

Note 13 of the Form 10-Q for the quarter ended June 30, 2026 carries a figure that was dismissed as immaterial a year earlier. Tesla recognized $318 million of revenue in the second quarter of 2026 from selling Megapack products to SpaceX, and $405 million in the first half. The related cost of revenue: $242 million and $307 million.

For context: the entire energy generation and storage segment produced $3,139 million of revenue in the same quarter. A single related-party customer therefore accounts for roughly 10 percent of it. In the prior-year quarter Tesla simply wrote that related-party transactions were immaterial.

The gross profit on that business — $318 million less $242 million — implies a margin of about 24 percent, above the segment margin of 20.4 percent in the same quarter. None of this need mean anything. It is, however, exactly why such transactions carry a separate disclosure requirement: buyer and seller are run by the same person.

In March 2026 Tesla invested $2.00 billion in SpaceX common stock. Note 13 states the position arose from a former preferred-share investment in xAI and represents an ownership interest of less than one percent. Because the chief executive runs both companies, Tesla presumes significant influence over the investee and carries the stake at fair value.

As of June 30, 2026 it was carried at $3.007 billion. The remeasurement gain for the quarter: $1.00 billion, booked to other income. Pre-tax income for the same quarter was $1,329 million — so the unrealized gain equals roughly 76 percent of it.

Two dates sit inside that footnote. The fair value includes a $238 million discount for lack of marketability tied to regulatory restrictions expiring in September 2026. Tesla is separately subject to customary sales restrictions from the SpaceX initial public offering that expire in December 2026. Both dates change the measurement basis — in either direction.

The cover page of the Form 10-Q for the quarter ended June 30, 2026 carries a precise number: as of July 16, 2026 there were 3,949,547,394 shares of common stock outstanding. Three pages later, in the income statement, a very different one appears: only 3,237 million shares went into basic earnings per share for the quarter, 3,540 million on a diluted basis. That leaves roughly 712 million shares between cover page and income statement — 18 percent of the equity.

The explanation sits in Note 1 and Note 9. Restricted stock stays out of the calculation until the shares are deemed earned. During the second quarter of 2026 the chief executive exercised roughly 304.0 million options under the compensation award granted in 2018 and net-settled the exercise price with about 17.5 million shares. The resulting shares have carried a service condition since April 21, 2026 running through January 19, 2028, followed by a five-year holding period. In exchange, 96 million shares from an interim award dated August 3, 2025 were forfeited.

On top of that sit 423,743,904 shares from the award granted on September 3, 2025, which vote proportionately with all other shares until they are earned. For valuation this matters: anyone dividing Tesla's market capitalization by the cover-page share count is using a different denominator than Tesla's own income statement.

The legal section of the quarterly report (10-Q) for the quarter ended March 31, 2026 carries a concrete date. Trial in the New Mexico Attorney General's case, which has expanded to include claims related to content moderation, is scheduled to begin on September 8, 2026. Meta adds that the Attorney General has indicated an intention to seek penalties of up to $62.85 billion in that case.

For context: stockholders' equity stood at $243,681 million as of March 31, 2026. The amount sought therefore equals roughly 26 percent of equity and more than the whole of 2025 net income ($60,458 million). An award of that size is not the most likely outcome of such a case — but the number is in the filing, and it comes with a date.

It is not the only open item. In the same report Meta writes that the maximum aggregate damages or penalties sought across its various legal proceedings could amount to up to hundreds of billions of dollars and could therefore be material to the financial condition of the company.

At the annual meeting on May 27, 2026 a shareholder proposal on the dual-class capital structure was once again on the agenda. Meta reported the result in an 8-K filed May 29, 2026: 1,312,681,056 votes in favor, 3,647,675,248 against. The proposal failed.

The arithmetic behind it sits in the same filing. Present or represented by proxy were 1,758,006,749 Class A shares carrying one vote each and 342,307,492 Class B shares carrying ten votes each. The Class B shares alone therefore carried roughly 3.42 billion votes — the 3.65 billion block of votes against cannot be assembled without them. Put the other way: of the Class A holders present, a large majority voted to end the structure.

In the risk factors of the same quarterly report Meta describes the consequence itself: holders of Class B stock, including the founder, Chairman and CEO, together hold a majority of the combined voting power and can therefore decide the outcome of every matter submitted to shareholders, as long as the Class B shares represent at least 9.1 percent of all outstanding shares. As of April 24, 2026 that share was 342,377,716 out of 2,538,423,304 — 13.5 percent. There is still room above the threshold.

In the quarter ended March 31, 2026 Meta reported income before income taxes of $21,752 million and, below it, net income of $26,773 million. Profit after tax was therefore some five billion dollars higher than profit before it. That is possible because the tax line was not an expense but a benefit of $5,021 million.

Meta gives the reason itself: the effective tax rate was negative 23 percent and reflected an income tax benefit of $8.03 billion from the transitional relief for the U.S. Corporate Alternative Minimum Tax under Treasury Notice 2026-7. Excluding that item, the rate would have been 14 percent. For the remaining quarters of 2026 the company guides to 13 to 16 percent.

The mirror image sits in the annual report for 2025. There the tax package enacted in July 2025 (the One Big Beautiful Bill Act) pushed the rate to 30 percent, because Meta booked a $15.93 billion charge in the third quarter of 2025, $14.03 billion of it a valuation allowance against U.S. federal deferred tax assets. Absent that charge, the 2025 rate would have been 13 percent. Two changes in the law, two one-off effects pointing in opposite directions — and both times the difference travelled through the profit line.

Note 8 of the quarterly report (10-Q) for the quarter ended March 31, 2026 contains a sentence that is easy to skip. On top of the lease liabilities carried on the balance sheet, Meta has signed leases whose terms have not yet begun. The volume: roughly $182.88 billion, mostly data centers, colocation space and network infrastructure. They commence between the remainder of 2026 and 2036, with terms ranging from more than one year to 30 years.

Three months earlier, as of December 31, 2025, the annual report put the same item at about $103.77 billion. In a single quarter, therefore, roughly $79 billion of new, not-yet-commenced lease obligations were added. For context: stockholders' equity stood at $243,681 million as of March 31, 2026, and reported long-term debt at $58,748 million.

The same note lists $237.67 billion of non-cancelable contractual commitments, with about $42.25 billion due in 2026 and $47.65 billion in 2027, plus contingent obligations to purchase up to $14.72 billion of cloud capacity over five years. And in April 2026, the report says, non-cancelable commitments increased by roughly another $24 billion. None of that appears on the balance sheet.

On October 17, 2025 chief financial officer Mala Murthy told the company she would resign effective November 21, 2025. In its Form 8-K of October 23, 2025 Teladoc Health told the U.S. securities regulator, the SEC, that it had begun a search process to identify a new chief financial officer. That process is still unfinished. The Form 10-K for 2025, filed February 26, 2026, and the Form 10-Q for the quarter ended March 31, 2026, filed April 30, 2026, carry the same signature: Charles Divita, III, “Chief Executive Officer and Principal Financial Officer.” The proxy statement (DEF 14A) of April 7, 2026 lists “Interim Principal Financial Officer (2025 to present)” in his biography.

For more than eight months, then, a single person has signed both Sarbanes-Oxley certifications — the chief executive's and the principal financial officer's. That is legally permissible and is flanked by a chief accounting officer (Joseph Catapano) and by Ernst & Young, ratified as auditor by shareholders on May 21, 2026. It is material nonetheless: this vacancy covers exactly the period in which the repayment or refinancing of $1,000.0 million of convertible notes due June 1, 2027 has to be prepared — 75 percent of the $1,336.3 million of book equity (March 31, 2026) and roughly 58 percent of the market capitalization. No 8-K under Item 5.02 announcing a successor had been filed through July 29, 2026.

Teladoc Health generates real money year after year: $350.0 million of operating cash flow (2023), $293.7 million (2024), $294.4 million (2025). That line is the strongest single argument against any collapse narrative. It is not, however, the amount that is left over. Further down the same cash flow statement sits the investing line “Capitalized software development costs”: $144.9 million (2023), $113.3 million (2024), $118.6 million (2025). This is development work on the company's own platform that never passes through the income statement as an expense — it is capitalized as an asset and amortized later, but the money leaves the bank exactly like a salary does.

Deduct it together with capital expenditure ($8.9 million in 2025) and free cash flow comes to roughly $166.9 million — some 43 percent less than the widely quoted operating line. In the first quarter of 2026 the calculation actually turns negative: $9.5 million of operating cash flow against $1.7 million of capital expenditure and $34.2 million of capitalized software, or roughly minus $26.3 million. The first quarter is seasonally the weakest at Teladoc, and the prior-year quarter confirms the pattern ($15.9 million operating against $28.9 million capitalized). The finding is material all the same: the $127.5 million gap between operating and free cash flow in 2025 equals 64 percent of the reported annual loss.

The BetterHelp segment is Teladoc's direct-to-consumer therapy marketplace, and it is no sideshow: $950.4 million of revenue in 2025, 38 percent of the consolidated total. What is remarkable is what that revenue costs. In the first quarter of 2026 the segment spent $116.8 million on advertising and marketing against segment revenue of $218.4 million, according to the Form 10-Q. That is 53 percent. For the full year 2025 the same arithmetic reads $518.5 million of advertising against $950.4 million of revenue, or 55 percent.

The user base is shrinking anyway. Average paying users fell 9 percent to 0.361 million in the first quarter of 2026 (0.397 million a year earlier) and segment revenue fell by the same percentage — even though the Uplift acquisition added roughly 6 percentage points to it. Segment adjusted EBITDA dropped from $7.7 million to $1.9 million, down 75 percent, and from $77.8 million (2024) to $41.9 million (2025) on an annual basis. All of the group's remaining goodwill hangs on this one segment: the $283.2 million left is assigned entirely to BetterHelp, or 21 percent of book equity. The same filing notes that market capitalization stayed below carrying value during the first quarter of 2026.

On May 19, 2020, at the height of the telehealth boom, Teladoc Health issued $1,000.0 million of convertible senior notes carrying a 1.25 percent coupon. Note 10 of the Form 10-Q for the quarter ended March 31, 2026 gives the maturity date: June 1, 2027. It also gives the conversion rate: 4.1258 shares per $1,000 of principal, which works out to a conversion price of roughly $242 per share. At $9.40 per share (data as of July 28, 2026) this is no longer a convertible — it is simply debt, and it has to be repaid in cash. Accordingly the company has reserved only 4.1 million shares against it: dilution risk is negligible, payment risk is not.

Against that sit $750.7 million of cash at March 31, 2026, plus a secured, so far undrawn $300.0 million revolving credit facility ($296.6 million available). The shortfall from cash alone is roughly $249 million, or about 15 percent of the $1.711 billion market capitalization (data as of July 28, 2026). The company already repaid earlier tranches totalling $550.6 million out of pocket in 2025 — which is precisely why cash fell from $1,298.3 million to $781.1 million. Free cash flow in 2025 was roughly $166.9 million ($294.4 million of operating cash flow less $8.9 million of capital expenditure and $118.6 million of capitalized software). At that pace the company gets there on its own, but without a cushion.

When a company pays more for a business than its individual assets are worth, the difference is recorded as goodwill — and it stays on the balance sheet until an impairment test knocks it off. At Teladoc Health that test has become a formality inside the Integrated Care segment, and it destroys every acquisition on arrival. Note 7 of the 2025 Form 10-K records that the company tested goodwill concurrently with the closings of Telecare and Catapult Health and found that the carrying value of the reporting unit continued to exceed its fair value. The result: $59.1 million of goodwill from Catapult Health (first quarter of 2025) and $12.6 million from Telecare Australia (third quarter of 2025) were written off in full in the quarter of purchase — $71.8 million for the year.

The filing also spells out what follows: if the carrying value of the Integrated Care unit exceeds its fair value at the date of any future business combination, further goodwill impairment charges could result. For investors that means every new acquisition in this segment is an immediate accounting loss, no matter how well the acquired business performs. The $71.8 million equals roughly 36 percent of the $200.3 million consolidated net loss for 2025 and a little over 5 percent of the $1,336.3 million of book equity (March 31, 2026) — comfortably above the materiality bar.

At the annual meeting on May 19, 2026 one result sits quietly among the election tallies in the current report (8-K, Item 5.07): on the advisory vote on executive compensation, 18,276,382 shares voted in favor and 7,493,052 against, with 723,057 abstentions. That works out to roughly 71 percent support of the votes cast for and against. The votes against equal about 22 percent of the 34.33 million shares the quarterly report's cover page lists as of April 30, 2026.

For comparison: ratifying KPMG as auditor at the same meeting drew 28,770,885 votes in favor against 802,840 opposed. The contrast shows this was not a matter of low turnout but a targeted objection to pay. Such a vote is legally non-binding, yet in the United States it effectively forces the board into dialogue with large holders — and usually shows up in the compensation discussion of the next proxy statement (DEF 14A). The article does not cover this topic.

Walker & Dunlop holds custodial accounts for the owners of the properties it finances — money set aside for property taxes, insurance and reserves that does not belong to the company and therefore never appears on its balance sheet. It is still allowed to earn on it: the fees run through the income statement as "placement fees and other interest income." That line brought in $32.7 million in the first quarter of 2026 — 10.9 percent of the $301.3 million of quarterly revenue. It is not purely a return on other people's money, though: per the annual report (10-K), the same line also carries interest on the company's own cash, on its pledged securities and on other investments.

The direction is the interesting part. Escrow deposits stood at $2.5 billion on March 31, 2026, above the year-earlier level of $2.4 billion on March 31, 2025. The apparent collapse from $3.1 billion on December 31, 2025 is an annual pattern: the five-quarter series in the earnings release runs $2.4 → $2.7 → $2.8 → $3.1 → $2.5 billion, so the balance builds through the year and falls back in the first quarter. Income fell even though the balance grew: $32.7 million against $33.2 million in the prior-year quarter, and for the full year $152.6 million in 2025 after $168.0 million in 2024. It is not the volume that is shrinking but the rate earned on it — the annual report attributes the 9 percent decline explicitly to lower short-term interest rates. And this single line ran at almost three times the $56.2 million of full-year 2025 profit.

The notes to the quarterly report (10-Q) for March 31, 2026 contain a sentence you do not expect from an agency lender: in 2025 the government-sponsored enterprises demanded the repurchase of two loan portfolios with an aggregate unpaid principal balance of $100.0 million — the reason being "fraudulent documentation submitted by the borrowers." Walker & Dunlop deferred the repurchase through forbearance and indemnification agreements: the first portfolio ($50.7 million of original unpaid principal balance) to the fourth quarter of 2027, the second ($49.3 million) to the first quarter of 2028. Until then the company indemnifies the buyer against losses.

The cost is already running. The allowance on indemnified and repurchased loans rose from $5.4 million to $29.1 million in a single quarter, and the total expense impact from this item went from $0.9 million (first quarter of 2025) to $13.0 million (first quarter of 2026) — 82 percent of the $15.9 million quarterly profit. In total the company has repurchased, agreed to repurchase or expects to indemnify $191.9 million of loans. Working the other way: it no longer considers a repurchase probable for $34.3 million as of the second quarter of 2026.

The most valuable item Walker & Dunlop owns is carried too low in the books — systematically so. The rights to service other people's loans and collect fees for it (mortgage servicing rights) are held under U.S. accounting rules at cost less scheduled amortization. As of March 31, 2026 that came to $795.8 million net: $1,844.1 million gross less $1,048.3 million of accumulated amortization. The notes to the quarterly report (10-Q) also disclose fair value — and that stood at $1.4 billion, the same as on December 31, 2025.

The difference of roughly $600 million equals a good third of the $1.75 billion market capitalization (34,331,241 shares at the July 28, 2026 closing price) and about 35 percent of the $1,720.2 million in equity. It is interest-rate sensitive, and the filing quantifies that itself: a 100 basis point increase in the discount rate costs $39.9 million of fair value, 200 basis points $77.0 million; a 50 basis point decline in the placement fee rate costs $50.3 million, 100 basis points $100.7 million. Anyone valuing the stock on book value is therefore using a measure that understates the largest asset by about $600 million — as long as the rate environment cooperates.

The balance sheet as of March 31, 2026 carries $741.2 million of goodwill, of which $424.4 million sits in the Commercial Services segment alone — more than the group's entire equity of $272.0 million. Goodwill is the premium a buyer paid above net asset value; it stays on the balance sheet for as long as the acquired business still supports the expectations of the day it was bought.

That is precisely the problem here. For fiscal 2025, Verra Mobility considered a purely qualitative assessment sufficient in its annual impairment test — including for Commercial Services. Then the customer left that, by the company's own figures, contributed $120 million to $125 million of segment profit. That this need not be harmless is something the company has already demonstrated: in 2024 it wrote off $97.1 million of goodwill in the Parking Solutions segment, pushing net income down to $31.4 million. A write-down of similar size would turn the profit line again — without a single dollar leaving the bank account.

The quarterly report for the period ended March 31, 2026 names three Commercial Services customers each above ten percent of total revenue: 13.3 percent, 11.9 percent and 10.0 percent, together 35.2 percent. One of them was Avis Budget Group, which terminated on May 26, 2026. The same risk section carries the sentence that governs the other two: "We will enter into contract renewal discussions with our other two significant Commercial Services customers over the next eighteen months …" The clock started on May 6, 2026, the day the report was filed.

The magnitude is considerable: together the two account for 21.9 percent of quarterly revenue — roughly $49 million, and therefore a good half of the Commercial Services segment revenue of $97.8 million in the first quarter of 2026. That assumes Avis was the largest of the three at 13.3 percent; the company attaches no names, but the $135 million to $145 million of revenue it says will fall away fits precisely that share. Since the segment earned a 64.8 percent segment margin in 2025, any further departure would hit profit disproportionately — exactly as it did with Avis, where $135 million to $145 million of revenue cost $120 million to $125 million of segment profit. Such a case would first surface where the Avis case first surfaced: in a Form 8-K under Item 8.01.

Between October 2025 and March 2026, Verra Mobility repurchased its own shares on a large scale. In the fourth quarter of 2025 the company paid $133.4 million for 6,028,853 shares (roughly $22.13 apiece); in the first quarter of 2026 it paid another $50.2 million for 2,215,800 shares (roughly $22.66). Together that is $183.6 million for 8.24 million shares at an average of about $22.27 — against a market value of roughly $0.64 billion as of July 28, 2026, the deployed amount equals nearly 29 percent of today's market capitalization.

About three months after the last of those purchases, Avis Budget Group served its termination notice (Form 8-K of May 26, 2026), and the stock fell to $4.18 (as of July 28, 2026). The interesting part sits in the quarterly report: as of March 31, 2026, $66.3 million of the authorization was still available — at that price roughly 15.9 million shares, or a good ten percent of all 151,906,653 shares outstanding. Per the quarterly report the buyback program expires on November 13, 2026 unless terminated or extended earlier. Whether the board deploys that remainder after the collapse, and at what average price, is the concrete question the next quarterly report answers.

In fiscal 2025 Broadcom reported income before income taxes of $22,729 million and, below it, net income of $23,126 million. Profit after tax was therefore higher than profit before tax. What makes that possible is a line you rarely see: instead of a tax provision there sat a tax benefit of $397 million. The annual report names the reasons — expiring statutes of limitations, settled tax examinations and tax benefits from stock-based compensation.

A second figure comes from the same report: tax incentives and a tax holiday reduced the tax provision by roughly $2,709 million in fiscal 2025 and raised diluted earnings per share by $0.56. Broadcom draws those benefits mainly from Singapore and Malaysia.

That is exactly where it gets tighter. Broadcom writes that the global minimum tax becomes effective in Singapore in fiscal 2026 and expects a material impact on results of operations and cash flows. In the first half of fiscal 2026 the same line already showed an expense of $1,666 million — against just $107 million in the prior-year period.

Broadcom discloses the figure itself, but far back in the quarterly report (Form 10-Q): direct sales to one semiconductor solutions customer — a distributor, according to the filing — accounted for 42 percent of consolidated net revenue, both for the quarter and for the six months ended May 3, 2026. A year earlier it was 29 percent. In fiscal 2025 and 2024 the same customer stood at 32 percent and 28 percent respectively.

So the share rose 13 percentage points in four quarters — in absolute terms from roughly $4.4 billion to roughly $9.3 billion per quarter. Over the same period the share of all distributors in revenue rose from 48 percent (fiscal 2025) to 56 percent in the first half of fiscal 2026. The top five end customers together came to roughly 45 percent, against 40 percent.

Broadcom spells out the consequence itself: the loss of, or a significant decrease in demand from, any of its top five end customers could have "a material adverse effect" on its business, results of operations and financial condition. Distributor agreements, the same report notes, are generally nonexclusive and some may be terminated at any time without cause.

The quarterly report (Form 10-Q) as of May 3, 2026 closes with a note nobody reads: "Subsequent Events". It states that on June 8, 2026 Broadcom arranged for an investor partner to take on agreements to purchase AI racks and the related lease agreements with a customer. Broadcom stays on the hook: it entered into a backstop for that customer's lease obligations over five-year terms, with a maximum exposure of $29 billion. Who the partner is does not appear in the note — it appears under "Other Information" in Part II of the very same report: Apollo.

For scale: stockholders' equity stood at $87,691 million as of May 3, 2026. The backstop therefore equals 33 percent of equity — and 45 percent of the $64,907 million of total debt carried on the balance sheet. It does not appear on that balance sheet at all. According to the filing it increases as the racks are deployed and decreases as the customer makes its lease payments. If the customer defaults, Broadcom may assume the lease or sell the racks, which would reduce the exposure.

Broadcom had described the pattern as a risk in the same report: large AI customers increasingly want to lease racks rather than buy them, along with "alternative financings" — and such arrangements could impose "financial obligations, including backstops or guarantees" on the company.

In August 2024 Ginkgo consolidated its stock 1-for-40 — forty shares became one. What did not change sits in the equity note of the annual report (10-K) for 2025: the charter still authorizes 15,800 million shares of common stock — 10,500 million Class A, 4,500 million Class B (ten votes each) and 800 million non-voting Class C — plus 200 million authorized preferred shares.

Outstanding as of April 30, 2026 were 65.3 million shares across all three classes. Authorized capital is therefore roughly 242 times the shares actually outstanding. The headroom is already in use: a $500 million shelf registration has been effective since August 14, 2025, including a sales agreement for up to $100 million, under which 1.9 million Class A shares were placed for $18.1 million of net proceeds through March 31, 2026.

The segment disclosure in the quarterly report (10-Q) as of March 31, 2026 carries a line item that is rarely this explicit: "Carrying cost of excess space (net of sublease income)" — $15.8 million in the first quarter of 2026, up from $11.7 million a year earlier. The footnote spells out what it covers: base rent, common area maintenance charges and real estate taxes for facilities the company is not occupying, net of any sublease income.

For scale: total revenue from continuing operations in the same quarter was $19.5 million. The empty space costs more than 80 percent of what the business takes in — and it rose 36 percent year over year, even though the annual report for 2025 described the site consolidation as largely complete. The filing itself concedes that subleasing may extend beyond 2026 or may not happen before the leases terminate, depending on market conditions.

Every Ginkgo headline leads with the same number: $373.5 million in cash and marketable securities as of March 31, 2026. The very last paragraph of the notes to the quarterly report (10-Q) qualifies it. Under "Subsequent Events" the company discloses that in April 2026 it was required to restrict $47.0 million to secure a surety bond of the same amount, tied to a contract with a U.S. Government National Laboratory for the sale of RAC automation equipment. Verbatim: "Currently the Company expects the cash to be restricted until 2029."

That is 12.6 percent of total liquidity tied up for about three years — and it does not show up in the March 31, 2026 balance sheet at all, because the restriction came afterwards. Added to the $44.8 million already restricted at the reporting date, roughly $91.8 million would be locked. Anyone running the runway math against management's guidance of $125 million to $150 million of cash burn for 2026 has to subtract this.

The number of shares outstanding appears twice in the quarterly report (10-Q) as of March 31, 2026 — and the two figures contradict each other. The statement of stockholders' equity closes its "Common Stock (Class A, B and Exchangeable) — Shares" column at 530,796,103 as of March 31, 2026. The balance sheet in the same report gives 530,628,653 shares "issued and outstanding" for that same date, broken down into 524,464,320 Class A, 5,307,334 Class B and 856,999 Exchangeable. The difference is 167,450 shares.

That stands out for two reasons. First, the two presentations agreed exactly on the preceding dates: as of December 31, 2025 both the balance sheet and the equity statement show 528,182,693 shares, and as of December 31, 2024 both show 396,802,394. Second, the machine-readable filing data (the XBRL element "CommonStockSharesOutstanding") follows the balance sheet, not the equity statement — anyone pulling the figure automatically gets 530,628,653.

At 0.03 percent the gap is immaterial to valuation. As an observation it is not: the auditor withheld its opinion on this company's internal control over financial reporting for fiscal 2025, and management again concluded that disclosure controls were "ineffective" as of March 31, 2026. A share count that appears twice in one document with two different values is exactly the kind of inconsistency such an opinion warns about.

Two audit opinions sit side by side in the annual report on Form 10-K for 2025. The first confirms that the financial statements present the position fairly. The second reads verbatim: "Also in our opinion, the Company did not maintain, in all material respects, effective internal control over financial reporting as of December 31, 2025." The reason: the acquired Exscientia business lacked effective processes and controls in the financial close as well as effective general information technology controls, including segregation of duties.

The company itself writes that these weaknesses could result in a misstatement of "substantially all account balances or disclosures." Materiality is therefore quantified by the company itself — it does not concern one line item but the entire set of statements. The weaknesses were first identified in connection with fiscal year 2024; as of March 31, 2026 management again concluded that disclosure controls were "ineffective." An older, separate weakness (revenue estimation under a license agreement) has been considered remediated since December 31, 2025.

Recursion has financed itself essentially by issuing its own shares since 2024. The quarterly report as of March 31, 2026 puts net proceeds from share issuances since 2024 at $829.0 million. In 2025 alone the company sold 99.9 million shares through a sales agreement with Citigroup for net proceeds of $491.7 million, exhausting that $500 million program in full.

In February 2026 a new $300 million program with TD Securities was put in place. The report states: "For the three months ended March 31, 2026, the Company sold no shares. As of March 31, 2026, an amount of $300.0 million remained available for future sales under the Sales Agreement." That $300 million equals roughly 19 percent of the market value of about $1.6 billion (data as of July 28, 2026) — an already authorized dilution facility available at any time. The share count rose from 191.0 million at the end of 2022 to 530.8 million as of March 31, 2026.

Recursion reports the direct cost of its partnership work on a separate line — "cost of revenue." On a full-year view it looks harmless: in 2023, $44.6 million of revenue against $42.6 million of cost; in 2024, $58.8 million against $45.2 million; in 2025, $74.7 million against $71.0 million. A gross profit was left every year — in 2025 just $3.7 million, or 5 percent of revenue.

The quarterly view contradicts that. In all four quarters Recursion has most recently reported separately, direct cost exceeded revenue: Q1 2025, $14.745 million against $21.829 million; Q2 2025, $19.223 million against $20.161 million; Q3 2025, $5.175 million against $14.687 million; and Q1 2026, $6.472 million against $12.490 million — most recently a gross loss of $6.0 million before a single dollar is spent on research, administration or the data center. Across the first nine months of 2025 the shortfall adds up to $17.5 million.

That the full year 2025 still ended in the black derives from a single quarter: full-year minus nine-month figures imply roughly $35.5 million of revenue against $14.3 million of cost in the fourth quarter of 2025, about $21.3 million of gross profit. That matters for valuation — the assumption that the partnerships help fund the platform only holds in the quarter in which a milestone is accepted.

Among NL Industries' non-current assets sits a line that is startling on second glance: 1.2 million shares of its own parent company, Valhi, Inc. (NYSE: VHI), which in turn owns roughly 83 percent of NL. Fair value as of March 31, 2026: $17.1 million, against a cost basis of $24.3 million — an unrealized loss of $7.2 million. As of December 31, 2025 the fair value was $14.4 million; the Valhi share price rose from $12.05 to $14.30 over the quarter.

The quarterly report (10-Q) states explicitly that as a majority-owned subsidiary of Valhi, NL cannot vote these shares under Delaware law, although it does receive dividends on them. The position still matters to investors because its change in value runs straight through the income statement: the "Marketable equity securities" line cost $8.6 million in the first quarter of 2025 and added $2.7 million in the first quarter of 2026 — against $4.3 million of net income attributable to NL stockholders. A block of shares that cannot be voted therefore drives a sizeable share of reported quarterly profit.

NL Industries quantifies its legacy environmental exposure with two numbers: the accrual it has booked and the upper end of what could reasonably still come. In the annual report (10-K) for 2025, as of December 31, 2025, those were roughly $13 million accrued for about 27 sites and an upper end of roughly $26 million. In the quarterly report (10-Q) for March 31, 2026 the accrual is unchanged — about $13 million for about 27 sites — but the upper end now stands at roughly $38 million. That is a jump of some $12 million, or 46 percent, in a single quarter, with no increase in the accrual.

For scale: $12 million equals roughly 7.6 percent of 2025 net sales ($158.3 million) and nearly three times the $4.3 million of first-quarter 2026 net income attributable to NL stockholders. On top of that, there are about five further sites for which the company says it cannot estimate a range of costs at all. The filing notes that any later adjustment could have "a material effect on our Consolidated Financial Statements."

On May 14, 2026 NL Industries shareholders voted on five proposals. Proposal 3 moved the state of incorporation from New Jersey to Delaware — by merging the company into its own Delaware subsidiary NLI Holdings, Inc., whose name it has carried ever since; Proposal 4 added a clause to the new certificate of incorporation under which the company opts out of Section 203 of the Delaware General Corporation Law. Both proposals carried 95.1 percent of the shares eligible to vote. The reincorporation became effective on May 26, 2026; the head office in Dallas and the NYSE ticker NL remain unchanged.

Section 203 is the statutory takeover brake: it generally bars a holder of 15 percent or more from completing a business combination with the company for three years unless specific approvals are obtained. That protection is now waived — with a majority holder that owned roughly 83 percent of NL as of March 31, 2026 (Valhi, Inc.) and a float of only about 8.3 million of the 48,862,734 shares outstanding (48,898,734 per Exhibit 4.1 to the same current report, as of May 26, 2026). Worth noting: for the reincorporation itself the plan of merger additionally required the approval of two-thirds of the voting stock not beneficially owned by Valhi, and that hurdle was cleared with 71.6 percent. For the structure that now stands, the implication is simple: a business combination with the majority holder is no longer blocked by statute.

On June 8, 2026, Amazon signed an unsecured $17.5 billion delayed draw term loan with a syndicate of lenders led by Citibank. The unusual part: the money is committed but not yet drawn. And the commitment has an expiry date.

In the words of the filing, the commitments expire on September 30, 2026 unless the facility is fully borrowed before then. Whatever is drawn matures three years after the draw date and carries interest at term SOFR plus 0.625 to 0.875 percent depending on Amazon's credit ratings — and amounts repaid may not be reborrowed. The agreement expressly contains no financial covenants.

For scale: $17.5 billion equals roughly 14 percent of the total face value of long-term debt as of March 31, 2026 ($122.6 billion). Together with the notes placed after the balance sheet date — C$13.967 billion on June 12 and $24.923 billion on July 9, 2026 — Amazon has built roughly $90 billion of financing capacity in five months. Whether the term loan gets drawn is therefore a direct read on how fast the capital spending keeps running.

On the balance sheet as of March 31, 2026, equity investments in private companies — essentially Anthropic and OpenAI — carry a value of $48.1 billion. Three months earlier the figure was $16.2 billion. What is not on the balance sheet is larger than what is.

First, OpenAI: Amazon invested $15.0 billion in Series C preferred stock during the first quarter of 2026 and signed a commitment letter agreement for an additional $35.0 billion. The note names the deadline: the obligations terminate if the commitment amount has not been invested by December 31, 2028, and that date may accelerate under certain circumstances. Second, Anthropic: after the balance sheet date Amazon added $5.0 billion of nonvoting preferred stock, made available a financing facility of up to $20.0 billion (expiring 30 months after a liquidity event such as an IPO) and secured an option to invest a further $5.0 billion.

For scale: the $35 billion OpenAI commitment alone equals roughly 8 percent of stockholders' equity as of March 31, 2026 ($441.9 billion) and about a quarter of cash plus marketable securities ($143.1 billion). Both counterparties also buy computing capacity from AWS — the very segment that delivers 56 percent of consolidated operating income.

The line "Other income (expense), net" is usually unremarkable at Microsoft. In the nine months ended March 31, 2026, it changed sign: from negative $3.194 billion a year earlier to positive $7.253 billion. The note explains why: the OpenAI investment contributed $5.9 billion of net gains to that line — the same stake had cost $2.7 billion in the prior-year period.

The filing also says where the gain came from: "The net gains recorded for the nine months ended March 31, 2026 primarily relate to the dilution gain from the OpenAI Recapitalization." It is a dilution gain — Microsoft's proportionate ownership of OpenAI fell in the restructuring, and because the smaller remaining stake carried a higher valuation, accounting produces income. No cash moves. Microsoft treats the item as non-recurring and removes it in its own reconciliation: $93.5 billion instead of $98.0 billion of adjusted net income, a gain of 22 percent rather than 31.

Look up Microsoft's debt and you land on the bonds: $40.3 billion in total debt as of March 31, 2026, of which $8.8 billion is current — and that is less than a year earlier ($43.2 billion as of June 30, 2025). A company deleveraging, you might think. Four notes later, in the lease disclosure of the Form 10-Q, sits the bigger number: $62.9 billion of finance lease liabilities, up from $46.2 billion nine months earlier. That is $16.8 billion added in nine months, while bond debt shrank by $2.9 billion.

These leases are the datacenters. The related assets sit on the balance sheet at $77.6 billion of cost (June 30, 2025: $53.9 billion). Undiscounted, the future payments total $84.6 billion, of which $57.0 billion falls due only after fiscal year 2030; the weighted average remaining lease term is 13 years and the weighted average discount rate 4.4 percent. The filing names the effect directly: interest expense rose "primarily due to higher finance lease interest expense."

This matters for reading the balance sheet. The lease liability is a real, long-dated, interest-bearing payment obligation — it simply does not appear on the line most investors read as "debt."

In January 2026 Unusual Machines received a $2.1 million order from Teal Drones, a subsidiary of Red Cat. The quarterly report spells out the link itself: "Red Cat is a related party as Jeff Thompson is the Chief Executive Officer of Red Cat and is also on the Board of Directors of Unusual Machines." The same person runs the customer and sits on the supplier’s board. In the first quarter of 2026 that produced roughly $0.7 million of revenue — 8.6 percent of the $8.096 million quarterly total — and $0.4 million of related-party receivables were still outstanding at March 31, 2026.

None of this is improper, and all of it is disclosed — historically Fat Shark and Rotor Riot belonged to Red Cat until February 2024. It still matters to the price: the order clears the materiality threshold, and it lands on a revenue base that already rests on few shoulders, with two customers accounting for 16.7 percent and 15.9 percent of 2025 revenue. Anyone extrapolating the growth curve should check the next report for how much of it came from the company’s own boardroom.

Buried in the "Recent Developments" section of the quarterly report as of March 31, 2026 is a sentence that is easy to skim past: "During the month of May, we are initiating purchase orders of inventory estimated to be approximately $75.0 million to secure materials and inventory across our drone component product lines." In May 2026 the company initiated purchase orders for roughly $75.0 million of materials and inventory. For comparison: revenue over the twelve months to March 31, 2026 was $17.253 million. The company is buying material worth more than four times its annual revenue in one move — tying up roughly a quarter of its $283.6 million in liquid assets.

The trend was already visible during the quarter: inventories rose from $5.317 million (December 31, 2025) to $13.827 million (March 31, 2026), and prepaid inventory from $9.748 million to $13.566 million. Together those two lines explain most of the $17.413 million of operating cash used in the quarter. A bet like this has two outcomes and both move the stock: if demand shows up, the company can ship when competitors cannot. If it does not, four years of revenue in parts sit on shelves in an industry where electronics age quickly — and the filing itself names "inventory management and potential obsolescence" as a risk.

Four days after the event date, on July 28, 2026, Unusual Machines disclosed a compensation decision taken on July 24, 2026: the compensation committee granted CEO Dr. Allan Evans warrants to purchase 5,000,000 shares at an exercise price of $25.00, expiring July 24, 2031. They vest in five equal tranches of 1,000,000 each, whenever the 20-day average closing price reaches $25, $40, $60, $80 and $100. In return, Evans waives all cash compensation from the company after December 31, 2026. On the same day three other executive officers received a combined 1,275,000 options at $19.36.

Scale is the point: 6,275,000 new instruments equal 13.1 percent of the 47,793,923 shares outstanding as of May 13, 2026 — far above the materiality threshold. The warrant package is explicitly subject to shareholder approval, which makes the vote an undated but clearly identified event that will first surface in a proxy statement (DEF 14A) and afterwards in the results filing (8-K, Item 5.07). Note also the anchor the company sets for itself: the lowest tranche does not vest until $25.00 — above the $19.36 at which the three other officers received their options on the very same day.

As of March 31, 2026 Unusual Machines held a securities portfolio worth $60.657 million — $48.157 million at fair value ($44.251 million in common stock, $3.221 million in pre-funded warrants, $0.685 million in non-public warrants) plus another $12.500 million carried at cost in privately held companies. The 2025 annual report names this as deliberate strategy: strategic investments in emerging leaders of the U.S. drone ecosystem. Measured against the portfolio alone it would be a footnote. Measured against earnings it is not: in the first quarter of 2026 that portfolio threw off $16.757 million in realized and unrealized gains — more than twice the quarter’s revenue of $8.096 million — turning a $7.259 million operating loss into a reported net profit of $10.283 million.

The actual find sits in the related-party note, which states verbatim: "On April 1, 2026, the Company paid $217,943 to its investment committee, which includes the CEO and two independent Directors of the Company. The payment is based on a 1% per committee member based on the realized gains during the previous quarter." The chief executive and two independent directors form an investment committee and each receive 1 percent of the prior quarter’s realized gains — a performance fee of the kind you find in fund management, inside an industrial company. The first such payment was $43,474 on December 31, 2025; the second was $217,943 on April 1, 2026, a fivefold increase in a single quarter. Once you know that line, you read every future earnings release differently: an incentive to realize gains bites hardest when it is paid on realized gains.

In the first quarter of 2026, AEVEX posted the highest quarterly revenue in its history: $216.7 million. Over the same three months, funded backlog shrank from $503.1 million to $356.6 million — down $146.5 million, or 29 percent. The quarterly report names both in one sentence: the decline was "primarily due to revenue recognized for the EUCOM AOR Deep Strike program." The record quarter and the shrinking order book are the same movement, seen from two sides.

The second figure in that paragraph matters more: 93.0 percent of the remaining backlog is expected to convert to revenue during the rest of 2026, leaving only 7.0 percent for 2027 and beyond. Absent new awards, that puts the first quarter of 2027 close to an empty order book. Management guidance issued on May 20, 2026 ($600 million to $620 million for the year) leaves $383 million to $403 million for the final nine months — an average of roughly $128 million to $134 million per quarter, well below the opening quarter.

In December 2025 the predecessor company raised $100.0 million through preferred units, and another $15.3 million followed in the first quarter of 2026. The buyer of the second tranche, per the quarterly report, was Radz Capital AEVEX Holdings Inc., whose president is the company's executive chairman. The decisive clause sits in the terms: on a qualified public offering the units convert at 80 percent of the offering price — at $20.00, that means $16.00. On April 20, 2026, 115,342 preferred units accordingly became 7,208,876 Class A shares.

What the discount costs is spelled out in a prospectus footnote: "Net loss available to AEVEX Corp. common stockholders includes a $28.5 million deemed dividend related to the assumed conversion of 115,342 Series A Preferred Units into 7,208,876 shares of Class A common stock." The amount equals the excess of the shares' fair value at the offering price over the carrying value of the preferred units — and it turns the 2025 pro forma net loss of $2.0 million into a $29.3 million loss attributable to common stockholders. On June 5, 2026, the same director then sold 104,722 units back to the company at $25.99 (Form 4 filed June 8, 2026).

At the IPO on April 16, 2026, AEVEX entered into a Tax Receivable Agreement with its pre-IPO owners. The mechanism: when those owners exchange their LLC units for shares, AEVEX picks up a tax benefit — and 85 percent of that benefit must be paid out in cash to those very same owners. Only 15 percent stays with the company, and therefore with new shareholders.

The June 5, 2026 prospectus works through an example: if all units were exchanged at the then-offering price of $27.00, the company would recognize a deferred tax asset of roughly $461.3 million and, against it, a noncurrent TRA liability of roughly $392.1 million. For scale: total equity of the operating company stood at $222.1 million as of March 31, 2026. The prospectus puts it plainly: "We expect that the payments we may make under the Tax Receivable Agreement will be substantial." An early termination of the agreement can even trigger an immediate lump-sum payment.

On June 5, 2026, seven weeks after the IPO, AEVEX placed 8,000,000 shares at $27.00 each — gross proceeds of $216.0 million. The prospectus cover states that 5,726,157 of those shares were offered by the company itself; only 2,273,843 came from selling securityholders. That reads like a capital raise in which fresh money enters the business. The "Use of Proceeds" section says otherwise: the roughly $148.8 million in net proceeds to the company will be used in full to buy back 5,726,157 Series B units and the matching Class B shares from existing members — including entities controlled by principal stockholder Madison Dearborn Partners. Not one dollar reaches production, development or debt reduction.

The Forms 4 filed on June 8, 2026 show the other side of the trade: Madison Dearborn vehicles sold 2,273,843 Class A shares at $25.99 per share and disposed of another 4,757,448 Series B units. A director also parted with 104,722 units at the same price. On the lock-up: the June 5, 2026 prospectus specifies the restricted period as April 16, 2026 through October 13, 2026, and it was expressly waived for the shares sold in this offering. After it lapses, another 57,571,367 Class B shares and matching units become exchangeable.

Sweaty Betty, the British activewear brand acquired in 2021, sits on Wolverine's books at $103.4 million of indefinite-lived trade name and $55.1 million of goodwill (as of April 4, 2026) — $158.5 million together, or 38.1 percent of equity attributable to Wolverine shareholders ($415.7 million). A further $48.4 million has already been written off on this unit.

The quarterly report names the remaining margin of safety from the 2025 annual impairment test: estimated fair value exceeded carrying value by only 16 percent. The company itself writes that a future impairment could have "an adverse material effect on the Company's consolidated financial results." Sweaty Betty revenue fell by $6.1 million in 2025. A test standing at a 16 percent cushion is a test that can tip in the next weak year.

Wolverine sells its trade receivables continuously and without recourse to Rockford ARS, its own bankruptcy-remote subsidiary, which passes them on to outside purchasers. The purchase agreement is capped: up to $125.0 million. As of April 4, 2026, $120.7 million of that was drawn and derecognized from the balance sheet — 96.6 percent. A year earlier the figure was $102.6 million, or 82.1 percent.

This is not a footnote. Per the notes, the proceeds of the program run through the cash flow statement as operating inflows — $149.1 million of receivables sold in the first quarter of 2026 alone. For comparison: receivables reported on the balance sheet total only $185.5 million. Once the facility is full, the extra push disappears; any expansion of the business would then have to be funded elsewhere — through the revolving facility, which still had $492.9 million available on April 4, 2026. The agreement runs to September 25, 2028 after the extension of September 25, 2025.

On February 20, 2026 the U.S. Supreme Court ruled that the import tariffs imposed under the emergency statute IEEPA were unauthorized. In its quarterly report (10-Q) as of April 4, 2026, Wolverine World Wide puts the IEEPA tariffs paid up to the date of the ruling at approximately $36 million. The reimbursement process has been open since April 20, 2026. Booked so far: nothing — "no loss recovery of any IEEPA tariffs paid has been recorded."

The magnitude matters: $36 million equals roughly 38 percent of 2025 net earnings attributable to shareholders ($95.8 million) and 1.6 times the first quarter 2026 net earnings ($22.4 million). If a refund arrives in whole or in part, it shows up as a one-off item in some future quarter without anything changing in the operating business. If it never arrives, nothing changes at all — an asymmetric item currently carried at zero.

On June 3, 2026 Worthington Steel completed its acquisition of 60,710,791 shares in Klöckner & Co SE — roughly 60.86 percent of the share capital, or approximately 62 percent measured against the outstanding shares, as the company puts it in its financial release of July 10, 2026; the 52,389,508 tendered shares alone cost 576,284,588 euros. Two days earlier it had funded the deal with $700 million of senior secured notes at 7.750 percent due June 1, 2033 and a $700 million term loan. At the date of the last published balance sheet — May 31, 2026, unaudited — the company carried $256.8 million of debt and $84.6 million of cash.

The completion filing says the company will file the acquired business's financial statements and the pro forma financial information by amendment to that 8-K, "no later than 71 calendar days" after the date the report was required to be filed — which points into August 2026. Wait only for that, though, and you miss the fact that both are already public: on May 26, 2026, in connection with the notes offering, Worthington Steel filed Klöckner's audited 2025 financial statements (Exhibit 99.2) and an unaudited pro forma condensed combined set (Exhibit 99.3). It shows, as of February 28, 2026, combined total assets of $6,106.1 million, total liabilities of $4,290.6 million, long-term debt of $2,274.9 million and total equity of $1,718.7 million — on trailing twelve-month pro forma net sales of $9,702.7 million. Enterprise value and leverage are therefore approximable after all; what is still outstanding is only the formally filed, audited version under Item 9.01.

Worthington Steel owns 50 percent of Serviacero Worthington in Mexico, a steel service center that is not consolidated but carried at equity — it shows up as a single line, the share of its earnings. In fiscal 2026 that line came to $20.3 million, up from $4.4 million the year before and $22.4 million in fiscal 2024. Hold it next to the other number: net earnings attributable to controlling interest were $8.5 million in fiscal 2026, and pre-tax earnings were $7.1 million.

In other words: without the Mexican contribution, fiscal 2026 pre-tax earnings would have been negative. That is a sign flip resting on an affiliate the company does not operate — and whose figures come in on a one-month lag. The quarterly report as of February 28, 2026 shows the swing behind it: Serviacero earned $33.3 million over nine months against $0.9 million a year earlier, and in February 2026 the venture distributed $35.0 million to its members, $17.5 million of it to Worthington Steel.

On June 3, 2025 Worthington Steel, through its Tempel Steel subsidiary, bought 52 percent of Italy's S.I.T.E.M. S.p.A. — total consideration $66.3 million, of which $21.5 million was recorded as goodwill. Sitem makes electric motor laminations. Twelve months later, in the fourth quarter of fiscal 2026, the company booked $112.2 million of impairments on goodwill and long-lived assets in the Electrical Steel reporting unit — $53.8 million against goodwill, $58.4 million against long-lived assets. The stated reason: weak demand for industrial motors in Europe and the United States on rising foreign competition, plus delayed automotive program launches.

The size is material: $112.2 million equals a little more than six percent of the roughly $1.84 billion market value (data as of July 28, 2026). Consolidated goodwill fell from $79.6 million (May 31, 2025) to $44.5 million (May 31, 2026). An unusually large share landed on the minority holders: $29.1 million of the impairment was attributable to noncontrolling interests — a hint at how much of it sits inside the majority-owned but not wholly owned Sitem group. Sitem itself contributed a net loss of $8.2 million on net sales of $133.8 million over the first nine months of fiscal 2026.

On June 24, 2026 Worthington Steel reported $0.34 in diluted earnings per share for the fiscal year ended May 31, 2026. On July 10, 2026 it filed an amendment to that release on Form 8-K/A, attaching a corrected version that, in its own words, "supersedes the Original Financial Release in its entirety." The result of the correction: $0.17 per share — half. Operating income of $15.5 million became an operating loss of $1.4 million. It was already the second correction of the same release: the June 25, 2026 filing states in its own words that it attached a corrected version of the previous day's press release, because a footnote in the non-GAAP reconciliation table had been erroneously duplicated from another.

The catch for valuation: a financial release under Item 2.02 is only furnished to the U.S. securities regulator, the SEC, not formally filed — and data services usually pull their figures from the first announcement. Anyone looking at a trailing price-to-earnings ratio of 108.1 for Worthington Steel as of July 28, 2026 was looking at a number built on the withdrawn $0.34. On the corrected $0.17, the same ratio is roughly 216. The proof will come with the annual report (10-K) for fiscal 2026: that is where the audited figure sits, and that is where the auditors state whether internal control over financial reporting was effective.

On July 14, 2026 stockholders approved a charter amendment that has gone largely unreported: authorized common stock was raised from 700,000,000 to 4,000,000,000 shares — almost six times as many. Outstanding as of June 5, 2026 were only 488,846,722 shares. On paper the company may now issue more than seven times what exists today.

The stated reason in the proxy statement is factual: the headroom is meant to cover shares issuable on conversion of the new 7.50 percent notes, under the purchase warrants, and under the expanded incentive plan. The filings put numbers on it: a maximum of 498,389,410 shares from note conversion, 135,789,000 from the purchase warrants and 33,402,727 from the prefunded warrants — together roughly 667 million potential new shares, enough by itself to more than double the count. On top of that comes the incentive plan, whose increase the company estimates at approximately 77 million further shares, in addition to the 69,238,008 already reserved as of March 31, 2026. The rest is reserve. The same meeting also authorized the board to effect a reverse split, whose charter amendments would proportionately reduce the authorized capital again. Until that step is taken — the company expects it "in or promptly following the third quarter of 2026" — a dilution headroom sits on the table that few investors have on their radar.

The headline of July 27, 2026 reads: Gossamer takes back worldwide development and commercial rights to seralutinib without paying anything upfront — Chiesi even pays $5 million. The same 8-K contains a clause that appears in no press release: the intellectual property rights assigned and licensed by Chiesi may be revoked if Gossamer breaches its undisputed payment obligations under the Rights Reacquisition Agreement, subject to certain specified cure periods.

For a company with exactly one product candidate that is an existential question. Going forward Gossamer owes success-based milestones and a capped royalty on net sales. Failing to make those payments — because cash is tight around a launch, say — risks not merely a penalty but the intellectual property behind its only asset. The company names the dependency in the same document: "the Company's future performance is dependent entirely on the success of seralutinib".

In the note exchange of June 4, 2026, $181.1 million of the $200.0 million of old 5.00 percent convertible notes due 2027 were tendered — 90.5 percent. The 8-K names the remainder precisely: $18,948,000 remains outstanding. That stub is small, but it carries a fuse. The indenture for the new secured 7.50 percent notes contains a springing maturity: the $65.2 million that would otherwise be due on July 1, 2030 becomes due on March 2, 2027 if more than $4.0 million of the old notes are still outstanding at that time.

In plain terms: unless Gossamer pushes the remaining $18.9 million below $4 million, a note with four years to run turns into one that must be repaid within months — against a preliminary cash position of $57.0 million as of June 30, 2026 and a contractual minimum liquidity of $40 million. That is not a footnote; it is the difference between "funded to 2030" and "refinancing in winter". Anyone watching this stock should track that single number.

In June 2016 Capricor received about $3.4 million from the California Institute for Regenerative Medicine (CIRM) to support the early HOPE-Duchenne trial. Because the company held the option to convert the award into a loan, it was never booked as income but sat on the balance sheet as a liability for a decade. On February 26, 2025 Capricor actually exercised that option — and the grant became an interest-bearing loan. The annual report (10-K) for 2025 records non-cash interest expense of $3,045,725 for it; the total liability stood at about $6.4 million as of December 31, 2025 ($3.4 million of principal plus $3.0 million of accrued interest). The accrued interest alone could, on the company's own estimate, reach up to $7.7 million — which would put the total liability at roughly $11.1 million.

This is the only interest-bearing debt the company carries — and it flipped 2025 interest expense from zero to $3.0 million, close to three percent of the year's loss. The quarterly report as of March 31, 2026 puts the balance at $6,339,862, entirely current. In April 2026 a repayment agreement was being finalized: about $3.4 million within three calendar days of execution and a further $2.9 million no later than June 12, 2026. Whether that happened is not stated in any filing submitted so far — the next quarterly report will have to show it.

Thirteen days after Capricor disclosed the date of the FDA advisory committee meeting (current report 8-K of June 26, 2026), the company signed a lease on July 9, 2026 for roughly 171,000 rentable square feet at 9625 Towne Centre Drive in San Diego — a new headquarters with expanded manufacturing cleanrooms. The current report (8-K) of July 14, 2026 gives the numbers: initial base rent of $5.60 per rentable square foot per month, or about $958,000 a month, rising 3.0 percent a year, over a term of 138 months starting from the first full month after rent commencement. The security deposit is about $958,000.

The real find is how long it takes before any of it is paid: the term begins on the earlier of the date the lease contingency tied to FDA approval is satisfied or waived, or December 31, 2026 at the latest. The rent commencement date falls twelve months after that term commencement, and only from rent commencement do the eighteen fully rent-free months run, followed by six months in which rent is payable on only 128,068 square feet. The first rent payment therefore does not fall due until roughly two and a half years after the term begins, and full rent on the entire premises only after about three years — for the cash position of the next several quarters the lease is not a cost item at all.

Measured against equity of $278.7 million (March 31, 2026), the starting rent alone — roughly $11.5 million a year — is a real number: it equals a good tenth of the 2025 net loss of $105.0 million. The clause at the end is the interesting part: if Capricor does not receive FDA approval for deramiocel by December 31, 2026, either side may terminate the lease by written notice within five business days after that date. The lease is therefore itself a bet on the same decision as the stock — and it is not on the balance sheet yet: as of March 31, 2026 only $0.8 million of current and $13.9 million of non-current lease liabilities from the existing premises are recorded.

In the first quarter of 2026 Bladex earned $56.4 million against $51.7 million in the year-earlier quarter, up 9 percent. Reported earnings per share fell over the same span from $1.40 to $1.31. The explanation sits in note 18 of the interim statements: $7,500 thousand of coupon on the other equity instruments is deducted from the profit for the period; $48,855 thousand is left attributable to common shareholders.

That coupon belongs to the first hybrid bond in the bank's history: $200 million of additional tier 1 capital (AT1), perpetual, non-cumulative, carrying 7.50 percent and issued on September 12, 2025. The board approved the first payment on February 10, 2026 and it was wired on March 18, 2026. Annualized that is roughly $15 million taken off before the earnings-per-share line — about 6.6 percent of the $226.9 million earned in 2025. Anyone laying profit growth and earnings per share side by side has to know about that step, or they will read a decline where there is none.

The price-to-free-cash-flow ratio works with the last four quarters. At Bladex those four quarters are wildly uneven. The interim financial statements imply an operating cash inflow of $874.8 million for the second quarter of 2025 (the half-year figure of $1,071.4 million less the first quarter's $196.6 million), $308.6 million for the third quarter (against a nine-month figure of $1,379.9 million) — and minus $599.7 million for the fourth quarter, because the audited full-year figure comes to $780.2 million. The first quarter of 2026 was back at plus $214.2 million. Across all five quarters profit sat quietly between $51.7 and $64.2 million.

So the rank hangs on a rolling window. Once the 2026 half-year statements are out, the record quarter of Q2 2025 with its $874.8 million drops out of the twelve-month window and is replaced by the second quarter of 2026. If the new figure comes in materially lower, the twelve-month total falls with it and the ratio rises — without anything having changed in the business. Anyone who found this stock through that ratio should read the line “Net cash provided by operating activities” in the next interim statements themselves.

When a stock trades below the one-dollar mark for too long, expulsion from the exchange looms. That is exactly where Offerpad ended up: the price fell below the minimum-price requirement of the New York Stock Exchange. Management's answer was a 1-for-10 reverse split, effective June 9, 2026 — ten old shares were combined into one new one, the stock received a new CUSIP and has traded at an optically ten times higher price ever since. None of that changes the value of the company; it is pure cosmetics to avoid a delisting. It had been preceded in January 2026 by a capital increase: 10 million new shares (a pre-split count) for $18 million. First diluted, then consolidated — both the marks of a stock under pressure.

At first glance it looks like good news: Offerpad reported a positive operating cash inflow of $66.8 million for 2025 — more than three times the prior year. But the annual report (10-K) gives away where it came from: the inflow resulted "primarily from a $109.4 million decrease in real estate inventory" — in other words, from selling through aged homes while the buying pace was deliberately throttled. That is cash flow out of a shrinking balance sheet, not out of profit: it dries up as soon as the stock of homes has been sold. Anyone treating the stock as cheap because of a low price-to-cash-flow ratio is measuring it by a one-off effect that cannot be repeated.

Behind Prairie's growth stands a financing mechanism whose catch only shows up on a close reading. The credit facility with Citi is a reserve-based lending facility (RBL): its limit — the so-called borrowing base — is set by the value of the oil and gas reserves and is redetermined by the banks twice a year. At the middle of 2025 the base was confirmed at $475 million, of which $361.5 million was drawn as of March 31, 2026. The report warns about it itself: "Difficulties in the credit markets may cause the banks to be more restrictive when redetermining the borrowing base." The delicate part: if the oil price falls, the value of the reserves falls with it — and the banks can cut the limit at precisely the moment a leveraged producer like Prairie would need it most. The room for maneuver of a debt-financed growth story therefore does not lie in management's hands alone, but in those of a semi-annual bank review.

Read Prairie Operating's financing closely and you run into a money relationship between the company and its board that is worth knowing about. A subordinated note worth $5.0 million is held by two entities — First Idea Ventures LLC and The Hideaway Entertainment LLC — that are controlled by Jonathan H. Gray, a director of the company. Disclosed as a related party, that loan secures its holders, according to the report, a minimum return of up to 2.0 times the capital employed on repayment or on certain triggering events — plus warrants. Insider financings are not disreputable in themselves, least of all at young, capital-hungry companies. But a guaranteed doubling for a board member, while the public shareholders are diluted and see no dividend, is a governance point worth keeping on the invoice.

That MediaAlpha depends on a handful of large customers is well known and has been in the risk chapter for years: in 2025, two customers accounted for $540 million, or 49 percent of revenue (2024: two customers, $358 million, 41 percent), the largest alone for 25 percent. Far less attention goes to the other side of the marketplace — purchasing. There, concentration more than doubled within a year: in 2024, one supplier crossed the ten percent threshold at $75 million, or 11 percent of purchases. In 2025 there were two, together at $236 million, or 25 percent.

For a marketplace that is the more dangerous number. Customers can be replaced as long as the goods are there; if the goods are missing, the best customer does not help. And the contracts offer little support: the annual report states that most agreements contain no minimum volume commitments and that many partners can terminate without cause on 30 or 60 days' notice. Receivables sit just as close together: as of December 31, 2025, three customers above the ten percent threshold accounted for $59 million, or 49 percent of all receivables — a year earlier it was two customers at $66 million, or 46 percent.

MediaAlpha reported net income of $26.8 million for 2025. The line above it reads: loss before income taxes, $111.1 million. In between sits an income tax benefit of $137.8 million — driven in essence by the release of the valuation allowance on deferred tax assets. That is why the balance sheet as of December 31, 2025 shows, for the first time, "Deferred tax assets" of $149.7 million; a year earlier the line was empty. As of March 31, 2026 it stood at $143.7 million.

A deferred tax asset is a bet on your own future: it is only worth something if enough taxable income arrives later to use it against. The size makes this the central balance sheet question — $143.7 million equals 39.1 percent of total assets of $367.7 million as of March 31, 2026. If the valuation allowance had to be re-established, the already negative equity of minus $29.1 million would move toward minus $170 million on paper, without anything changing in the operating business.